Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009991	li-ace	— (—)	1367	1421	100.00%	Distribution not available
3009991	li-ace	u/l (u/l)	1118	1201	2.83%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Neurological diseases

748

328

11.59

307.65

1.1

1.0

1.02

1.09

u/l

0.94

320

154

Disturbances of skin sensation

483

602

8.28

307.65

1.1

1.05

1.06

u/l

0.20

203

264

Demyelinating diseases of the central nervous system

493

178

31.74

307.65

1.1

0.99

1.04

u/l

0.90

194

Other symptoms and signs involving the nervous and musculoskeletal systems

618

727

8.72

307.65

1.1

1.05

1.06

u/l

0.15

293

299

Other demyelinating diseases of the central nervous system

271

41.01

307.65

1.1

1.00

1.05

u/l

0.42

115

MS-disease / Multiple Sclerosis

405

147

31.47

307.65

1.0

1.1

0.95

1.03

u/l

1.70

143

Other degenerative diseases of the nervous system

560

47.65

307.65

1.1

1.0

0.99

1.16

u/l

1.38

223

Symptoms and signs involving the nervous and musculoskeletal systems

798

992

8.22

307.65

1.1

1.05

1.09

u/l

0.54

385

429

Neurological diseases, wide definition

341

31.59

301.33

1.1

1.00

0.96

u/l

0.49

149

Abnormal findings on diagnostic imaging of central nervous system

208

24.64

287.70

1.1

1.06

1.05

u/l

0.12

103

Disorders of optic nerve and visual pathways

258

196

13.98

274.99

1.2

1.1

1.06

1.11

u/l

0.34

105

Visual disturbances and blindness

539

1005

5.45

272.57

1.1

1.05

u/l

0.05

245

451

Visual disturbances

521

947

5.60

271.19

1.1

1.04

1.05

u/l

0.10

238

428

Polyneuropathies and other disorders of the peripheral nervous system

299

314

9.79

255.71

1.1

1.07

1.10

u/l

0.30

157

Postprocedural disorders of nervous system

217

160

14.48

235.56

1.1

1.0

1.02

1.05

u/l

0.19

Other and unspecified polyneuropathies, also in other diseases

268

272

10.15

235.09

1.1

1.08

1.12

u/l

0.31

140

138

Headache

601

1070

4.54

228.36

1.1

1.06

1.03

u/l

0.45

272

474

Symptoms and signs involving the skin and subcutaneous tissue

625

1498

4.13

224.98

1.1

1.05

1.08

u/l

0.46

266

700

Autoimmune diseases related-to ILD

720

1640

3.79

221.70

1.1

1.01

1.09

u/l

1.71

286

778

Other neurological diseases

582

1044

4.43

213.63

1.1

1.08

1.09

u/l

0.15

262

492

Autoimmune diseases excluding thyroid diseases

809

1208

3.68

204.85

1.1

1.02

1.08

u/l

1.10

344

542

Autoimmune diseases excluding thyroid diseases, strict definition

781

1173

3.68

197.48

1.1

1.02

1.08

u/l

0.97

331

524

Optic neuritis

154

17.71

184.69

1.1

1.0

0.96

1.04

u/l

0.98

ILD medications: immunosuppressive drugs

535

1258

3.99

181.43

1.1

1.0

1.04

1.09

u/l

0.65

244

557

Diplopia

197

201

10.11

172.30

1.1

1.02

1.15

u/l

1.69

100

Concussion

236

231

8.39

164.54

1.1

1.0

1.07

1.10

u/l

0.22

103

110

ILD medications

796

1407

3.09

155.61

1.1

1.03

1.08

u/l

0.96

359

620

Symptoms and signs involving cognition, perception, emotional state and behaviour

697

1511

3.17

153.24

1.1

1.08

1.07

u/l

0.10

288

708

Intracranial trauma

256

239

7.57

152.95

1.1

1.0

1.06

1.10

u/l

0.27

112

113

Encephalitis

114

20.63

146.51

1.4

1.0

1.08

1.07

u/l

0.08

Inflammatory diseases of the central nervous system

164

167

10.25

143.98

1.3

1.1

1.12

1.11

u/l

0.05

Autoimmune diseases

736

1214

3.10

141.76

1.1

1.04

1.08

u/l

0.50

319

545

Other encephalitis

109

21.17

141.58

1.4

1.1

1.08

u/l

0.03

Subjective visual disturbances

262

463

5.76

140.91

1.1

1.08

u/l

0.01

124

211

General symptoms and signs

720

1158

3.14

140.14

1.1

1.09

1.03

u/l

0.63

326

516

Used for control exclusion in common control thyroid runs

683

1115

3.11

132.05

1.1

1.02

1.08

u/l

0.82

302

494

Abnormalities of gait and mobility

140

137

10.48

126.07

1.1

1.12

1.16

u/l

0.16

Sarcoidosis

182

250

7.49

125.36

1.4

1.0

1.21

1.10

u/l

0.83

131

Other symptoms and signs involving cognitive functions and awareness

309

630

4.51

122.41

1.1

1.14

1.06

u/l

0.74

126

314

Other disorders of optic [2nd] nerve and visual pathways

131

123

11.17

121.89

1.2

1.0

1.13

1.15

u/l

0.06

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

422

1089

3.50

117.41

1.1

1.08

1.10

u/l

0.19

213

501

Benign intracranial hypertension

46.95

116.70

1.2

1.1

1.11

1.05

u/l

—

Certain disorders involving the immune mechanism

207

369

5.72

110.49

1.3

1.0

1.19

1.08

u/l

0.98

109

175

Nerve, nerve root and plexus disorders

675

1537

2.71

109.70

1.1

1.05

1.08

u/l

0.38

322

682

Malaise and fatigue

326

668

3.96

105.12

1.1

1.10

1.04

u/l

0.62

146

291

Dizziness and giddiness

467

1200

3.11

104.28

1.1

1.04

1.08

u/l

0.53

207

561

Papilloedema, unspecified

19.38

103.78

1.3

1.0

1.10

1.08

u/l

0.08

Diagnoses used for exclusion with ILD

216

437

5.01

99.98

1.3

1.1

1.19

1.08

u/l

1.19

114

199

ILD medications: prednisolone, methylprednisolone, prednisone

638

1374

2.61

94.40

1.1

1.05

1.08

u/l

0.44

298

608

Use of teriflunomide

31.65

92.53

1.0

1.1

0.97

1.17

u/l

—

Episodal and paroxysmal disorders

653

1314

2.54

89.03

1.1

1.03

1.05

u/l

0.41

285

600

Cerebral cysts

105

113

9.67

88.54

1.2

1.0

1.06

1.05

u/l

0.05

Migraine

384

1004

3.13

87.29

1.1

1.05

u/l

0.04

176

433

Other soft tissue disorders, not elsewhere classified

594

1361

2.57

86.68

1.1

1.06

1.08

u/l

0.19

263

609

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

210

178

5.95

86.48

1.1

1.0

1.05

1.01

u/l

0.39

106

Diseases of the eye and adnexa

522

928

2.83

86.48

1.1

1.0

1.01

1.11

u/l

1.48

230

415

Paralytic strabismus

102

110

9.58

85.76

1.1

1.08

1.14

u/l

0.36

Bell's palsy

136

208

6.69

84.86

1.1

1.11

u/l

0.05

101

Other headache syndromes

296

882

3.38

80.76

1.1

1.10

1.05

u/l

0.71

122

386

L04AX Other immunosuppressants

385

1340

2.90

80.67

1.2

1.1

1.05

1.08

u/l

0.35

187

598

L04AA Selective immunosuppressants

210

497

4.29

80.25

1.1

1.03

1.07

u/l

0.49

232

Second line medication for Crohn's disease

391

1382

2.85

79.63

1.2

1.1

1.06

1.08

u/l

0.23

190

613

Other dorsopathies, not elsewhere classified

599

1282

2.46

77.13

1.1

1.02

1.07

u/l

0.84

261

558

Dorsalgia

585

1277

2.47

76.44

1.1

1.02

1.07

u/l

0.68

256

557

Disorders of ocular muscles, binocular movement, accommodation and refraction

350

1181

2.96

76.33

1.1

1.04

1.05

u/l

0.07

153

502

Cerebrovascular diseases (FINNGEN)

245

452

3.87

73.53

1.1

1.15

1.13

u/l

0.08

107

215

Cerebral palsy and other paralytic syndromes

127

210

6.18

73.44

1.1

1.14

1.11

u/l

0.16

106

Small fibre neuropathy

15.88

72.16

1.1

1.0

1.08

1.11

u/l

0.11

Pain in joint

334

691

3.10

69.99

1.1

1.07

u/l

0.03

154

316

Infections, IBD-co-morbidities

21.57

69.92

1.1

1.0

1.06

1.05

u/l

—

Care involving use of rehabilitation procedures

389

1341

2.68

69.56

1.1

1.17

1.05

u/l

0.61

166

618

Systemic atrophies primarily affecting the central nervous system

11.38

67.14

1.1

1.08

1.09

u/l

0.08

Pain in limb

481

1316

2.46

66.66

1.1

1.07

1.08

u/l

0.09

206

587

Low back pain

434

1231

2.54

65.83

1.1

1.05

1.07

u/l

0.13

181

541

Oral corticosteroids

602

1605

2.24

65.49

1.2

1.0

1.09

1.06

u/l

0.28

285

711

Cerebrovascular diseases

367

937

2.77

65.11

1.1

1.10

1.11

u/l

0.06

160

463

First line medication for Crohn's disease

626

1534

2.22

64.96

1.1

1.0

1.06

1.05

u/l

0.05

293

663

Condition for Implicit Sepsis (Organ dysfunction codes)

505

1482

2.36

64.69

1.1

1.05

1.07

u/l

0.17

219

681

Medical observation and evaluation for suspected diseases and conditions

367

653

2.89

63.58

1.1

1.05

1.11

u/l

0.55

164

309

Dorsopathies

575

1288

2.28

62.60

1.1

1.03

1.07

u/l

0.52

253

560

Disorders of thyroid, IBD co-morbidities

13.94

62.21

1.1

1.0

1.02

0.99

u/l

0.14

Strabismus

214

615

3.51

61.86

1.1

1.07

1.06

u/l

0.06

101

276

Anxiety disorders, excluding more controls

483

1334

2.37

61.37

1.1

1.04

1.08

u/l

0.50

213

623

Migraine with aura

204

574

3.59

61.16

1.1

1.01

1.06

u/l

0.68

253

Inflammatory bowel disease treatment related agents

636

1676

2.13

60.77

1.1

1.0

1.08

1.06

u/l

0.23

296

738

Epilepsy

194

528

3.69

60.72

1.1

1.08

1.07

u/l

0.04

242

Implicit Sepsis

437

1320

2.43

60.64

1.1

1.03

1.08

u/l

0.83

191

608

Condition for Implicit Sepsis (Organ dysfunction codes)

461

1374

2.38

60.51

1.1

1.05

1.07

u/l

0.23

198

644

Abnormal involuntary movements

111

196

5.75

59.97

1.0

1.1

1.00

1.13

u/l

1.69

Guillain-Barre syndrome

19.24

59.96

1.1

1.0

1.03

1.16

u/l

0.47

Pain, not elsewhere classified

178

466

3.85

59.26

1.0

1.1

1.23

1.07

u/l

0.35

193

Other special examinations and investigations of persons without complaint or reported diagnosis

358

653

2.79

58.24

1.1

1.01

1.11

u/l

1.03

146

309

Anxiety disorders

525

1696

2.17

55.32

1.1

1.04

1.08

u/l

0.58

232

760

Neurotic, stress-related and somatoform disorders

519

1692

2.16

54.07

1.1

1.04

1.08

u/l

0.61

229

760

General examination and investigation of persons without complaint and reported diagnosis

339

653

2.72

53.42

1.1

1.02

1.11

u/l

0.95

148

309

Lower back pain or/and sciatica

569

1808

2.06

52.19

1.1

1.04

1.07

u/l

0.57

255

814

STROKE

313

798

2.68

52.03

1.1

1.10

1.12

u/l

0.14

140

388

Myalgia

170

479

3.59

50.95

1.1

1.08

u/l

0.00

206

Other acute disseminated demyelination

18.98

50.39

1.1

0.99

1.09

u/l

0.36

Neuromuscular dysfunction of bladder

159

5.84

49.83

1.2

1.1

1.02

1.07

u/l

0.44

Mood disorders, excluding more controls

497

1383

2.15

49.77

1.1

1.03

1.08

u/l

0.75

202

645

Other intervertebral disc disorders

422

1108

2.30

49.59

1.1

1.08

u/l

0.03

195

494

Depression

532

1752

2.07

49.43

1.1

1.03

1.08

u/l

0.95

215

814

Fever of other and unknown origin

271

909

2.67

47.81

1.1

1.12

1.04

u/l

1.09

140

403

Mood [affective] disorders

548

1777

2.01

46.61

1.1

1.03

1.08

u/l

0.98

220

824

Mood disorders

548

1777

2.00

46.39

1.1

1.03

1.08

u/l

0.98

220

824

Persons encountering health services for specific procedures and health care

572

1741

1.98

45.88

1.1

1.14

1.04

u/l

0.76

251

780

Pain (limb, back, neck, head abdominally)

348

704

2.49

45.65

1.1

1.04

1.07

u/l

0.48

159

320

Any reimbursement code in KELA

370

778

2.40

44.92

1.1

1.05

1.04

u/l

0.13

163

344

Sciatica+with lumbago

270

975

2.56

44.28

1.1

1.02

1.09

u/l

0.90

130

432

Implicit Sepsis

364

1210

2.28

44.27

1.1

1.03

1.08

u/l

0.88

155

572

Dysphagia

142

394

3.63

43.60

1.1

1.08

1.07

u/l

0.05

178

Stroke, excluding SAH

256

701

2.68

43.46

1.1

1.09

1.12

u/l

0.14

111

354

Systemic connective tissue disorders

198

677

2.95

43.21

1.1

1.13

1.08

u/l

0.40

306

Soft tissue disorders

536

1379

2.01

43.20

1.1

1.01

1.08

u/l

1.29

233

612

Other disorders of lacrimal gland

208

736

2.85

42.66

1.1

1.01

1.08

u/l

1.36

320

Other antidepressants

510

1294

2.03

42.05

1.1

1.02

1.09

u/l

1.42

230

590

Lumbar disc prolapse

319

1048

2.35

41.64

1.1

1.14

1.08

u/l

0.44

138

465

Migraine without aura

159

491

3.27

41.40

1.1

1.11

1.06

u/l

0.28

207

Enlarged lymph nodes

106

248

4.32

41.29

1.1

1.04

1.06

u/l

0.16

107

Ischaemic Stroke, excluding all haemorrhages

235

647

2.72

41.21

1.1

1.10

1.12

u/l

0.13

103

321

Stroke, including SAH

266

765

2.53

40.44

1.1

1.10

1.11

u/l

0.09

116

383

Other disorders of eye and adnexa

120

315

3.86

40.08

1.1

1.03

1.10

u/l

0.85

142

Spirochaetal infections, other/unspecified

164

5.16

39.83

1.1

1.23

1.15

u/l

0.27

Convulsions, not elsewhere classified

140

403

3.46

39.77

1.1

1.03

1.04

u/l

0.10

178

Sixth [abducent] nerve palsy

9.06

39.48

1.2

1.0

1.09

1.11

u/l

0.12

Disorders of lacrimal system

227

883

2.58

38.50

1.1

1.03

1.07

u/l

0.73

102

381

Depression or dysthymia

330

791

2.31

38.37

1.1

1.03

1.11

u/l

0.85

136

372

Anxiety (asthma-related co-morbidities)

368

1344

2.13

38.19

1.1

1.03

1.09

u/l

0.74

158

605

Implicit viral Sepsis

150

474

3.19

37.57

1.2

1.1

1.06

u/l

0.03

217

Other lack of coordination

14.32

36.77

1.1

1.00

1.01

u/l

0.08

Non-invasive ventilation

148

415

3.21

36.45

1.1

1.02

1.07

u/l

0.67

196

All anxiety disorders

375

1442

2.06

36.16

1.1

1.03

1.08

u/l

0.66

160

626

Recurrent or chronic depression

236

655

2.55

36.03

1.1

1.07

1.13

u/l

0.32

297

Examination and observation for other reasons

271

646

2.44

35.84

1.1

1.06

1.11

u/l

0.32

306

Other and unspecified visual disturbances

180

4.68

35.69

1.0

1.1

0.98

1.14

u/l

1.95

Tramadol

395

1185

2.06

35.62

1.1

1.09

1.08

u/l

0.06

172

527

Any mental disorder

524

1391

1.89

35.57

1.1

1.04

1.08

u/l

0.71

232

650

Opioids

509

1397

1.90

35.26

1.1

1.03

1.07

u/l

0.66

210

621

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

474

1728

1.90

35.10

1.2

1.1

1.20

1.03

u/l

1.57

229

774

Migraine with aura and triptan purchases

138

437

3.20

34.61

1.1

1.04

u/l

0.03

175

Chorioretinal inflammation

8.77

34.55

1.2

1.1

1.16

1.09

u/l

0.25

Spondylopathies

341

948

2.16

34.54

1.1

1.15

1.09

u/l

0.54

153

436

Pain in throat and chest

437

1350

1.95

33.99

1.1

1.06

1.09

u/l

0.20

198

608

Ocular pain

177

4.60

33.62

1.1

1.05

1.13

u/l

0.70

Codeine

477

1375

1.89

33.09

1.1

1.03

1.07

u/l

0.73

202

613

Depression medications

194

348

2.82

32.37

1.1

0.99

1.01

u/l

0.14

134

Focal epilepsy, mode (most common among epilepsy diagnosis)

120

364

3.33

32.26

1.1

1.05

1.08

u/l

0.21

171

Persons encountering health services for examination and investigation

295

653

2.27

32.23

1.1

1.05

1.11

u/l

0.51

132

309

Viral infections of the central nervous system

180

4.47

32.03

1.2

1.1

1.54

1.10

u/l

0.53

Third [oculomotor] nerve palsy

11.92

32.02

1.0

1.03

1.14

u/l

0.51

Other general symptoms and signs

6.69

31.93

1.1

1.0

1.04

1.16

u/l

0.56

Spondylosis

221

745

2.43

31.78

1.1

1.12

1.11

u/l

0.01

349

Radiculopathy

207

4.14

31.50

1.0

1.1

1.00

1.09

u/l

1.06

Cardiovascular diseases

379

1016

2.01

31.32

1.1

1.03

1.05

u/l

0.21

168

431

Focal epilepsy

130

422

3.11

31.23

1.1

1.05

1.07

u/l

0.13

190

Any gastric operation

406

1035

1.97

31.22

1.1

1.05

u/l

0.06

177

445

GASTRO-related operations

406

1035

1.97

31.22

1.1

1.05

u/l

0.06

177

445

Focal epilepsy, strict definition

121

377

3.24

31.15

1.1

1.06

1.08

u/l

0.13

176

Other anxiety disorders

288

1186

2.12

30.26

1.1

1.05

u/l

0.03

123

513

Malignant neoplasm of brain, including Hilmo

5.87

29.82

1.1

1.35

1.08

u/l

1.18

Hypothyroidism, strict autoimmune

301

943

2.11

29.56

1.1

1.11

1.07

u/l

0.31

140

418

Other/unspecified dorsalgia

180

709

2.53

29.47

1.1

1.04

1.11

u/l

0.59

302

Extrapyramidal and movement disorders

170

659

2.59

29.36

1.1

1.02

1.07

u/l

1.19

316

Other systemic involvement of connective tissue (FG)

136

469

2.88

28.65

1.1

1.16

1.06

u/l

0.67

211

Fibromyalgia

179

4.25

28.64

1.1

0.99

1.08

u/l

0.92

Syncope and collapse

179

610

2.52

28.30

1.1

1.07

1.05

u/l

0.09

275

Other specific joint derangements/joint disorders

400

1385

1.87

28.20

1.1

1.06

1.07

u/l

0.09

187

612

Disorders of vestibular function (Vertigo)

210

902

2.30

27.87

1.1

1.11

1.06

u/l

0.44

428

Diseases of the musculoskeletal system and connective tissue

284

661

2.16

27.72

1.1

1.03

1.10

u/l

0.58

131

277

Speech disturbances, not elsewhere classified

140

4.63

27.30

1.1

1.09

1.14

u/l

0.24

Use of glatiramer acetate

8.75

27.23

1.0

1.1

0.93

1.07

u/l

0.96

Malignant neoplasm of brain

6.84

26.87

1.1

1.25

1.08

u/l

0.71

Viral infections of the central nervous system

171

4.23

26.86

1.3

1.1

1.57

1.10

u/l

0.52

ILD differential diagnosis

379

995

1.91

26.82

1.1

1.0

1.05

1.08

u/l

0.28

175

436

Cardiovascular diseases (excluding rheumatic etc)

379

1157

1.89

26.79

1.1

1.04

1.05

u/l

0.07

171

509

COPD differential diagnosis

379

996

1.91

26.74

1.1

1.05

1.08

u/l

0.27

175

437

Asthma, excluding more controls

360

972

1.94

26.68

1.1

1.0

1.03

1.08

u/l

0.44

159

429

Asthma

363

989

1.93

26.65

1.1

1.0

1.03

1.08

u/l

0.40

161

435

Viral encephalitis, not elsewhere classified/unspecified

10.37

26.64

1.4

1.0

2.15

1.14

u/l

0.49

Abnormalities of breathing

438

1421

1.80

26.45

1.1

0.99

1.08

u/l

2.13

192

631

Cervicalgia

107

345

3.12

26.10

1.1

1.08

1.09

u/l

0.02

152

Hard cardiovascular diseases

358

1125

1.90

26.08

1.1

1.09

1.11

u/l

0.21

169

547

Other systemic involvement of connective tissue

140

524

2.69

26.03

1.1

1.15

1.08

u/l

0.41

238

ILD medications: azathioprine

287

3.34

25.82

1.3

1.0

1.13

1.09

u/l

0.25

127

Use of peginterferon beta-1a

34.87

25.82

1.0

1.1

0.96

0.99

u/l

—

Hemiplegia

5.48

25.75

1.1

0.97

1.10

u/l

1.12

Diseases of the myoneural junction and muscle

203

3.83

25.70

1.1

1.05

1.15

u/l

0.36

106

Excluding asthma or asthma-COPD overlap

376

1001

1.89

25.57

1.1

1.0

1.04

1.08

u/l

0.31

172

439

Asthma (mode)

354

995

1.91

25.42

1.1

1.0

1.04

1.08

u/l

0.34

154

436

Cervical disc disorders

152

601

2.54

25.28

1.1

1.12

1.14

u/l

0.10

280

Disorders of eyelid, lacrimal system and orbit

382

1605

1.81

25.21

1.1

1.03

1.09

u/l

0.80

183

714

Oedema, not elsewhere classified

127

453

2.78

25.14

1.1

1.08

1.06

u/l

0.13

200

Other disorders of urethra and urinary system

325

1230

1.91

25.12

1.1

1.10

1.04

u/l

0.74

158

539

Symptoms and signs involving the circulatory and respiratory systems

492

1433

1.72

25.05

1.1

1.04

1.08

u/l

0.50

213

635

Other meningitis

9.50

24.89

1.3

1.1

1.30

1.09

u/l

0.77

Anaemias

130

295

2.89

24.88

1.1

1.49

1.02

u/l

0.79

114

Codeine or tramadol medication

533

1749

1.67

24.77

1.1

1.03

1.07

u/l

0.84

227

790

Symptoms and signs involving speech and voice

162

667

2.44

24.75

1.0

1.1

1.02

1.07

u/l

0.67

301

Other pulmonary diagnosis

372

1001

1.87

24.53

1.1

1.0

1.05

1.08

u/l

0.29

166

439

Visual field defects

128

4.59

24.51

1.1

1.24

1.18

u/l

0.13

Diseases of inner ear

228

1052

2.10

24.30

1.1

1.10

1.06

u/l

0.39

497

Other diseases of spinal cord

7.25

24.26

1.1

1.0

1.16

1.00

u/l

1.19

Symptoms and signs involving the digestive system and abdomen

446

1275

1.76

24.25

1.1

1.12

1.06

u/l

0.37

199

575

Viral Sepsis

100

324

3.11

24.23

1.2

1.1

1.04

1.07

u/l

0.37

154

Disorders of optic nerve, not elsewhere classified

9.38

23.98

1.1

1.0

1.16

1.11

u/l

0.07

Primary_lymphoid and hematopoietic malignant neoplasms

109

374

2.93

23.90

1.3

1.0

1.26

1.06

u/l

1.35

175

Malignant neoplasm of eye, brain and central nervous system

5.76

23.88

1.1

1.33

1.06

u/l

1.17

Alzheimer disease, excluding more controls

7.53

23.85

1.1

1.02

1.32

u/l

0.99

Implicit viral Sepsis

323

3.09

23.72

1.2

1.1

1.04

1.07

u/l

0.38

153

Somatoform disorder

107

366

2.95

23.63

1.1

1.07

1.09

u/l

0.12

164

Other disorders of binocular movement

7.03

23.49

1.1

0.98

1.05

u/l

0.42

Parkinson's disease, excluding more controls

8.38

23.27

1.1

1.0

0.99

1.32

u/l

0.94

Symptoms and signs involving the urinary system

319

1308

1.86

23.07

1.1

1.09

u/l

0.06

137

611

Parkinson's disease, strict definition, excluding more controls

8.94

22.99

1.1

1.0

0.97

1.32

u/l

0.85

Meningitis

111

4.78

22.95

1.2

1.1

1.27

1.08

u/l

1.19

Psychiatric diseases

437

1262

1.74

22.94

1.1

1.04

1.07

u/l

0.47

188

602

Other necrotizing vasculopathies (FG)

5.25

22.70

1.2

1.1

1.06

1.12

u/l

0.35

Other and unspecified nerve root and plexus disorders, also in other diseases

108

381

2.86

22.56

1.1

1.13

1.07

u/l

0.39

174

Provisional assignment of new diseases of uncertain etiology

255

1304

1.96

22.52

1.1

1.09

1.04

u/l

0.54

123

568

Persons encountering health services in other circumstances, wide

518

1625

1.64

22.41

1.1

1.07

1.08

u/l

0.08

231

738

Other extrapyramidal and movement disorders in other diseases

115

421

2.75

22.40

1.1

1.04

1.09

u/l

0.63

199

Codes for special purposes

255

1307

1.96

22.37

1.1

1.09

1.04

u/l

0.54

123

568

Migraine without aura and triptan purchases

123

467

2.66

22.36

1.1

1.13

1.03

u/l

0.69

185

Follow-up examination after treatment for conditions other than malignant neoplasms

187

546

2.27

22.34

1.0

1.1

0.95

1.12

u/l

1.88

257

Triptan medication for migraine, single purchase ok

396

1547

1.74

22.30

1.1

1.06

1.07

u/l

0.15

177

680

Migraine, single triptan purchase ok & required. ICD-code if available is included

396

1547

1.74

22.30

1.1

1.06

1.07

u/l

0.15

177

680

Liquid cancers, helper endpoint

160

593

2.36

22.20

1.2

1.1

1.18

1.04

u/l

1.24

272

Diseases of the ear and mastoid process

544

1692

1.62

21.93

1.1

1.05

1.07

u/l

0.24

253

755

Sequelae of cerebrovascular disease

124

405

2.65

21.86

1.0

1.1

1.22

1.08

u/l

0.74

206

Other strabismus

130

511

2.55

21.82

1.1

1.05

1.06

u/l

0.12

235

Hypothyroidism (congenital or acquired)

149

331

2.56

21.78

1.1

1.04

1.01

u/l

0.32

128

Other facial nerve disorders

6.84

21.77

1.0

1.35

1.10

u/l

0.40

Azathioprine

320

3.00

21.60

1.3

1.0

1.13

1.06

u/l

0.65

139

Trigeminal neuralgia

101

4.83

21.53

1.1

1.07

1.15

u/l

0.37

Heterophoria

170

3.82

21.23

1.0

1.1

1.01

1.11

u/l

0.71

Covid-19 confirmed case

165

734

2.26

21.19

1.1

1.09

1.03

u/l

0.59

311

Disorders of refraction and accommodation

148

626

2.37

21.19

1.1

1.03

1.05

u/l

0.19

292

Hypothyroidism, levothyroxine purchases

147

330

2.53

21.11

1.1

1.05

1.01

u/l

0.34

127

Hypothyroidism and >3 levothyroxin purchases

147

330

2.53

21.11

1.1

1.05

1.01

u/l

0.34

127

Benzodiazepine use

452

1894

1.65

20.95

1.1

1.05

1.07

u/l

0.28

185

875

Factors influencing health status and contact with health services

128

234

2.75

20.77

1.1

1.07

1.05

u/l

0.19

111

Non-Hodgkin lymphoma, all, including Hilmo

196

3.55

20.72

1.3

1.1

1.31

1.06

u/l

1.19

Certain infectious and parasitic diseases

446

1335

1.68

20.68

1.1

1.08

1.02

u/l

1.33

210

574

Parasetamol

363

1041

1.77

20.45

1.1

1.01

1.08

u/l

1.08

161

457

Cervicobrachial syndrome

106

391

2.73

20.39

1.1

0.99

1.09

u/l

1.62

173

Asthma (only as main-diagnosis)

312

989

1.83

20.22

1.1

1.0

1.00

1.08

u/l

0.98

138

435

Other reaction to severe stress, and adjustment disorders

209

1040

2.02

20.15

1.1

1.01

1.05

u/l

0.56

452

Paraplegia, diplegia of upper limbs

8.17

20.11

1.2

1.1

1.39

1.11

u/l

0.74

Metabolic disorders

403

1461

1.69

20.01

1.1

1.09

1.07

u/l

0.12

182

654

Other diseases of urinary system

441

1502

1.65

19.97

1.1

1.08

1.06

u/l

0.22

202

672

Status epilepticus

7.10

19.97

1.1

1.0

0.99

1.14

u/l

0.88

Selective serotonin reuptake inhibitors

417

1294

1.69

19.95

1.1

1.02

1.09

u/l

1.40

182

590

Asthma (only as main-diagnosis), excluding more controls

309

972

1.82

19.70

1.1

1.0

1.00

1.08

u/l

0.95

138

429

Antihypertensive medication - note that there are other indications

344

1041

1.76

19.11

1.1

1.03

1.08

u/l

0.54

140

475

Atypical facial pain

5.02

18.79

1.1

1.07

1.05

u/l

0.07

Abdominal and pelvic pain

420

1275

1.66

18.76

1.1

1.11

1.06

u/l

0.27

187

575

Other necrotizing vasculopathies

118

4.21

18.62

1.2

1.1

1.07

1.19

u/l

0.81

Other symptoms and signs involving the urinary system

173

3.56

18.42

1.2

1.1

1.03

1.15

u/l

1.09

Persons encountering health services for other counselling and medical advice, not elsewhere classified

475

1625

1.59

18.40

1.1

1.08

u/l

0.06

214

738

Transient ischemic attack

169

648

2.12

17.89

1.1

1.10

1.07

u/l

0.21

319

Brachial plexus disorders

206

3.29

17.87

1.1

1.18

1.08

u/l

0.38

Asthma, unspecified (mode), excluding more controls

222

868

1.92

17.66

1.1

1.0

1.03

1.09

u/l

0.53

381

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

4.80

17.47

1.0

1.20

1.26

u/l

0.13

Asthma, unspecified (mode)

223

883

1.91

17.45

1.1

1.0

1.03

1.09

u/l

0.57

387

Implicit bacterial Sepsis

153

612

2.17

17.40

1.1

1.07

1.05

u/l

0.21

296

Lesion of lateral popliteal nerve

4.67

17.30

1.1

1.05

1.15

u/l

0.41

Neuralgia and neuritis, unspecified

4.71

17.06

1.1

1.18

1.20

u/l

0.05

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

145

669

2.17

16.97

1.1

1.04

1.05

u/l

0.07

292

Implicit bacterial Sepsis

137

547

2.23

16.79

1.2

1.1

1.07

1.05

u/l

0.18

266

Hypertensive diseases (excluding secondary)

262

841

1.82

16.66

1.1

1.07

u/l

0.01

108

377

Abnormal findings on diagnostic imaging of lung

157

726

2.08

16.42

1.2

1.1

1.17

1.08

u/l

0.66

350

Retention of urine

123

437

2.32

16.31

1.1

1.08

u/l

0.01

213

Polyuria

373

2.56

16.24

1.0

1.1

0.95

1.09

u/l

3.53

178

334

2.66

16.15

1.1

1.10

1.06

u/l

0.27

153

Other joint disorders

422

1405

1.59

16.14

1.1

1.04

1.07

u/l

0.37

185

616

Visual impairment including blindness (binocular or monocular)

4.27

15.97

1.2

1.0

1.06

1.22

u/l

0.90

Other disorders of fluid, electrolyte and acid-base balance

112

456

2.35

15.77

1.1

1.12

1.07

u/l

0.24

215

Iridocyclitis in diseases classified elsewhere

7.39

15.75

1.4

1.0

1.10

1.12

u/l

0.05

Dyspnoea

367

1694

1.60

15.71

1.1

1.03

1.09

u/l

1.10

170

772

Nausea and vomiting

115

490

2.31

15.67

1.1

1.22

1.06

u/l

0.99

216

Vocal cord dysfunction

202

3.04

15.63

1.0

1.1

0.98

1.03

u/l

0.46

102

Triptan medication for migraine, min. 3 purchases

308

1413

1.67

15.48

1.1

1.07

1.05

u/l

0.24

133

610

Coxibs

127

286

2.35

15.45

1.1

1.10

1.09

u/l

0.01

107

Other and unspecified dermatitis

224

1250

1.80

15.36

1.1

1.11

1.07

u/l

0.25

106

563

SLE (Finngen)

5.69

15.11

1.1

1.0

1.01

1.06

u/l

—

Irritable bowel syndrome

139

668

2.09

14.89

1.1

1.07

1.08

u/l

0.06

301

Shoulder lesions

289

1035

1.70

14.78

1.0

1.1

1.02

1.10

u/l

1.21

126

474

Pain in thoracic spine

264

2.78

14.73

1.1

0.99

1.09

u/l

1.07

117

Other diseases of upper respiratory tract

446

1519

1.53

14.70

1.1

1.03

1.09

u/l

0.98

220

676

Benign neoplasm of meninges

181

3.18

14.49

1.1

1.03

1.13

u/l

0.88

Rotator cuff syndrome

218

866

1.81

14.48

1.0

1.1

1.02

1.12

u/l

1.38

410

Benign neoplasm: Cerebral meninges

166

3.29

14.48

1.1

1.01

1.14

u/l

1.16

Bacterial infection, other or unspecified

193

903

1.86

14.47

1.1

1.10

1.07

u/l

0.20

104

420

Symptoms and signs concerning food and fluid intake

132

3.58

14.42

1.1

1.0

1.09

1.11

u/l

0.07

Bacterial Sepsis

154

658

2.01

14.39

1.1

1.16

1.05

u/l

1.06

313

Abnormal findings on diagnostic imaging of other body structures

224

2.92

14.34

1.2

1.1

1.16

1.11

u/l

0.16

107

Disorders of sclera, cornea, iris and ciliary body

237

1373

1.73

14.32

1.1

1.08

1.07

u/l

0.06

123

613

Dermatitis

253

1489

1.70

14.23

1.1

1.11

1.08

u/l

0.24

118

679

Chronic sinusitis

191

1041

1.84

14.16

1.1

1.01

1.09

u/l

1.17

456

Sleep disorders (combined)

475

1666

1.50

14.15

1.1

1.02

1.05

u/l

0.88

196

772

Oxycodone

133

576

2.10

14.13

1.1

1.13

u/l

0.00

283

Autonomic disorders

6.81

14.07

1.0

1.10

1.02

u/l

—

Endocrine, nutritional and metabolic diseases

376

1208

1.58

14.05

1.1

1.05

1.04

u/l

0.10

176

516

Abnormalities of heart beat

149

735

1.99

14.04

1.1

0.97

1.06

u/l

2.93

317

Certain infectious and parasitic diseases

317

965

1.65

14.03

1.1

1.06

1.03

u/l

0.47

162

403

Spinal stenosis

146

545

2.04

13.97

1.1

1.15

1.14

u/l

0.07

280

Bacterial infection, other or unspecified

207

978

1.79

13.79

1.1

1.09

1.07

u/l

0.23

110

455

Disorders of choroid and retina

287

1239

1.65

13.73

1.1

1.06

1.10

u/l

0.37

130

589

Gastrointestinal diseases

289

864

1.68

13.73

1.1

1.04

1.09

u/l

0.50

122

389

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

219

1219

1.75

13.72

1.1

1.00

1.10

u/l

1.59

548

Special screening examination for infectious and parasitic diseases

125

429

2.15

13.68

1.1

0.95

1.15

u/l

1.60

195

Non-Hodgkin lymphoma, all

5.16

13.65

1.3

1.1

1.73

1.14

u/l

1.17

Exclusions for E4_PCOS_BROAD

406

2.35

13.60

1.2

1.1

1.13

1.07

u/l

0.30

189

Optic atrophy

10.35

13.57

1.1

1.0

1.39

1.09

u/l

—

Ptosis of eyelid

178

3.12

13.56

1.2

1.0

1.00

1.14

u/l

1.64

Finngen Rheumatological endpoints

431

1627

1.51

13.54

1.1

1.08

1.06

u/l

0.25

191

729

Benign paroxysmal vertigo

113

521

2.18

13.51

1.1

1.11

1.07

u/l

0.18

252

Hypothyroidism, drug reimbursement

179

2.81

13.48

1.1

0.98

u/l

0.03

Cystitis

346

1305

1.58

13.42

1.1

1.09

1.04

u/l

0.67

151

569

Cervicocranial syndrome

174

3.13

13.41

1.1

1.06

1.08

u/l

0.13

Enthesopathies of lower limb, excluding foot

394

2.35

13.13

1.1

1.07

1.08

u/l

0.06

170

Lesion of ulnar nerve

241

2.76

13.13

1.0

1.1

1.04

1.12

u/l

0.63

119

Optic atrophy

9.62

13.07

1.1

1.0

1.39

1.11

u/l

—

Diseases of the respiratory system

277

831

1.67

13.02

1.1

1.08

1.10

u/l

0.15

120

370

Panic disorder

390

2.35

13.00

1.1

1.01

1.06

u/l

0.57

170

Hypothyroidism, other/unspecified

373

1603

1.53

12.98

1.1

1.10

1.05

u/l

0.51

174

690

Use of hypnotics and sedatives

442

1710

1.49

12.95

1.1

1.08

1.07

u/l

0.10

194

778

Organic, including symptomatic, mental disorders

151

548

1.97

12.93

1.1

1.12

1.08

u/l

0.31

285

Sleep apnoea

369

1558

1.54

12.92

1.1

1.15

1.07

u/l

0.34

161

716

Hypothyreosis and Thyroxine purchase for inclusion criteria

384

1659

1.52

12.89

1.1

1.10

1.06

u/l

0.50

181

714

Asthma (diagnoses ohter than nonallergic)

360

1964

1.52

12.67

1.1

1.01

1.08

u/l

1.76

159

878

Cluster headache, strict

4.82

12.62

1.1

1.0

1.07

1.08

u/l

0.04

Hypertension, essential

334

1206

1.57

12.57

1.0

1.1

1.11

1.08

u/l

0.24

146

564

Cluster headache, wide

4.73

12.38

1.1

1.0

1.07

1.08

u/l

0.05

Spirochaetal infections, other/unspecified

129

648

2.00

12.34

1.1

1.14

1.08

u/l

0.34

294

Hydrocephalus

3.77

12.26

1.1

1.0

1.39

1.17

u/l

0.54

Other spirochaetal diseases

130

657

1.99

12.23

1.1

1.14

1.08

u/l

0.36

299

Disorders of other endocrine glands

186

1036

1.77

12.23

1.1

1.16

1.04

u/l

1.02

452

Use of dimethyl fumarate

11.71

12.23

1.0

1.1

0.90

1.08

u/l

—

Myocarditis

4.00

12.18

1.2

1.1

1.09

1.08

u/l

0.03

Non-selective monoamine reuptake inhibitors

129

626

1.99

12.17

1.0

1.1

1.12

1.08

u/l

0.26

288

Dental pulpitis, including avohilmo

417

1840

1.47

12.03

1.1

1.04

1.07

u/l

0.53

175

832

Diseases of oesophagus, stomach and duodenum

434

1775

1.46

11.96

1.1

1.06

1.07

u/l

0.17

193

806

Personality disorders, excluding more controls

126

635

1.99

11.95

1.1

1.03

1.05

u/l

0.29

279

Other spirochaetal diseases

128

650

1.98

11.90

1.1

1.15

1.08

u/l

0.38

295

Asthma, including avohilmo

486

1905

1.44

11.89

1.1

1.02

1.08

u/l

1.02

220

852

Viral infections characterized by skin and mucous membrane lesions

175

983

1.78

11.85

1.2

1.1

1.11

1.09

u/l

0.10

444

Zoster [herpes zoster]

302

2.46

11.80

1.3

1.1

1.14

1.11

u/l

0.09

145

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.38

11.70

1.1

0.93

1.14

u/l

2.24

Dissociative [conversion] disorders

3.73

11.69

1.0

1.1

1.06

u/l

0.01

Asthma-related infections

234

1400

1.64

11.64

1.1

1.04

1.08

u/l

0.25

617

Asthma, hospital admission 2, infections

234

1400

1.64

11.64

1.1

1.04

1.08

u/l

0.25

617

Lyme disease

126

644

1.97

11.51

1.1

1.15

1.08

u/l

0.39

294

Retinal detachments and breaks

115

572

2.02

11.34

1.1

1.01

1.06

u/l

1.00

284

Myasthenia gravis

9.14

11.34

1.1

1.0

0.95

1.13

u/l

—

Functional dyspepsia

118

594

2.00

11.27

1.1

0.98

1.08

u/l

2.53

270

Viral infections characterized by skin and mucous membrane lesions

353

2031

1.49

11.24

1.1

1.06

1.07

u/l

0.14

177

892

Fall on same level

484

1862

1.42

11.22

1.1

1.03

1.07

u/l

0.69

211

831

Sleep apnoea, including avohilmo

391

1647

1.47

11.20

1.1

1.14

1.07

u/l

0.33

175

747

Neoplasms

362

1277

1.51

11.16

1.1

1.08

1.03

u/l

0.79

161

540

Cough

153

794

1.83

11.16

1.1

1.10

1.12

u/l

0.08

344

Monoplegia

8.83

11.12

1.2

1.0

1.53

1.11

u/l

—

Rheumatism, unspecified

217

2.69

11.07

1.1

1.10

1.13

u/l

0.09

104

Disorders of lipoprotein metabolism and other lipidaemias

280

1104

1.57

10.90

1.1

1.15

1.09

u/l

0.49

142

520

Disorders of the thyroid gland

385

1717

1.46

10.77

1.1

1.11

1.06

u/l

0.62

176

748

Hypermobility syndrome

144

3.10

10.76

1.0

1.1

1.05

u/l

0.03

Iridocyclitis

103

503

2.06

10.73

1.2

1.1

1.10

1.07

u/l

0.12

225

Benign neoplasms

418

1596

1.45

10.68

1.1

1.12

1.05

u/l

0.37

184

703

External causes of morbidity and mortality

291

932

1.57

10.66

1.1

1.06

1.07

u/l

0.08

134

405

Non-follicular lymphoma

146

3.04

10.48

1.2

1.1

1.17

1.18

u/l

0.01

Other external causes of accidental injury

345

1153

1.50

10.43

1.1

1.03

1.08

u/l

0.72

157

509

Pure hypercholesterolaemia

240

975

1.61

10.41

1.1

1.22

1.11

u/l

0.91

125

456

Chronic lower respiratory diseases

496

1894

1.40

10.40

1.1

1.03

1.08

u/l

0.78

217

856

Other medical care

149

744

1.81

10.39

1.1

1.34

1.04

u/l

0.93

343

Other disorders of central nervous system

9.11

10.38

1.1

1.0

1.16

1.05

u/l

0.47

Cramp and spasm

102

3.48

10.31

1.0

1.1

0.99

1.06

u/l

0.45

Dermatitis and eczema

444

1950

1.41

10.28

1.1

1.07

u/l

0.07

197

879

Implicit fungal Sepsis

107

3.40

10.27

1.4

1.1

1.07

1.18

u/l

0.58

Disorders of mineral metabolism

148

3.00

10.25

1.1

0.94

1.09

u/l

1.88

189

1124

1.67

10.22

1.1

1.01

1.04

u/l

0.25

480

Other heart diseases

210

831

1.65

10.15

1.1

1.07

u/l

0.00

366

Post-traumatic stress disorder

228

2.57

10.09

1.1

1.01

1.03

u/l

0.12

Disorders of synovium and tendon

202

1078

1.65

10.07

1.1

1.00

1.10

u/l

1.68

483

Osteopathies and chondropathies

204

1164

1.64

10.06

1.1

1.09

1.08

u/l

0.12

530

Other sleep disorders

166

2.85

10.04

1.1

1.0

1.07

1.13

u/l

0.26

Complications of medical and surgical care

281

1707

1.52

9.97

1.1

1.08

u/l

0.02

124

771

Hypo-osmolality and hyponatraemia

228

2.54

9.94

1.2

1.0

1.19

1.11

u/l

0.21

108

Intracranial injury

223

1327

1.59

9.88

1.1

1.05

1.08

u/l

0.19

596

Other disorders of nervous system

100

3.43

9.87

1.3

1.0

0.99

1.12

u/l

0.91

Arthropathies

399

1406

1.44

9.86

1.1

1.06

1.07

u/l

0.12

183

616

Complications of surgical and medical care, not elsewhere classified

386

1848

1.43

9.83

1.1

1.04

1.08

u/l

0.39

173

838

Traumatic subdural haemorrhage

5.20

9.81

1.3

1.0

0.98

1.24

u/l

—

Other and unspecified mononeuropathies, also in other diseases

4.75

9.79

1.1

1.0

1.01

1.16

u/l

1.04

Other arthritis (FG)

123

661

1.87

9.75

1.1

1.17

1.03

u/l

1.11

287

Myopia

324

2.27

9.74

1.1

0.98

1.05

u/l

0.55

139

Acute upper respiratory infections

406

1762

1.42

9.73

1.1

0.99

1.10

u/l

2.56

170

798

Other diseases of intestines

443

1798

1.40

9.72

1.1

0.99

1.08

u/l

2.61

187

813

Nonorganic sleeping disorders, excluding more controls

428

2.09

9.71

1.1

1.02

1.06

u/l

0.40

194

Constipation

320

1500

1.48

9.64

1.1

1.12

1.08

u/l

0.43

142

685

Other disorders of optic disc

8.63

9.64

1.2

1.0

0.95

1.08

u/l

—

Fasciculation

11.74

9.64

1.0

1.1

0.93

1.19

u/l

—

Mixed connective tissue disease

127

3.10

9.64

1.1

1.28

1.07

u/l

0.49

Explicit Sepsis

141

738

1.79

9.63

1.1

1.19

1.04

u/l

1.69

338

Gastro-oesophageal reflux disease

254

1426

1.54

9.60

1.1

1.07

1.08

u/l

0.12

118

655

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

139

781

1.79

9.55

1.2

1.1

1.09

1.07

u/l

0.12

349

Other shoulder lesions

172

2.75

9.43

1.1

1.0

1.08

1.13

u/l

0.26

Hypertensive diseases

328

1257

1.48

9.42

1.1

1.11

1.08

u/l

0.27

140

583

Acute sinusitis

235

1403

1.55

9.37

1.1

1.00

1.09

u/l

1.01

625

Carpal tunnel syndrome

204

1120

1.61

9.36

1.1

1.06

1.10

u/l

0.37

490

Fourth [trochlear] nerve palsy

4.97

9.35

1.0

1.32

1.13

u/l

—

Accidents

338

1153

1.47

9.32

1.1

1.04

1.08

u/l

0.58

144

509

Other mental disorders due to brain damage and dysfunction and to physical disease

151

2.86

9.31

1.1

1.15

u/l

0.00

Temporomandibular joint disorders, including avohilmo

216

1356

1.58

9.21

1.1

1.04

u/l

0.08

103

569

Hypertension

326

1255

1.47

9.16

1.1

1.11

1.08

u/l

0.26

139

581

Other and unspecified paralytic syndromes

8.52

9.13

1.0

1.15

1.08

u/l

—

Delirium, not induced by alcohol and other psychoactive substances

142

2.90

9.06

1.0

1.1

1.09

1.15

u/l

0.31

Hypopituitarism

154

2.82

9.00

1.2

1.1

1.20

1.06

u/l

0.37

Nystagmus and other irregular eye movements

7.65

9.00

1.1

1.0

0.94

1.13

u/l

—

Obesity related asthma

135

766

1.77

9.00

1.1

0.99

1.05

u/l

1.13

337

Undetermined asthma, excluding more controls

211

2.52

9.00

1.1

1.0

1.05

1.10

u/l

0.24

Undetermined asthma

211

2.52

9.00

1.1

1.0

1.05

1.10

u/l

0.22

Other specified/unspecified arthritis

109

579

1.89

9.00

1.1

1.19

1.04

u/l

0.98

252

Algoneurodystrophy

3.59

8.98

1.0

1.1

1.21

1.04

u/l

—

Other functional intestinal disorders

161

888

1.69

8.97

1.1

1.08

1.06

u/l

0.17

408

Other enthesopathies

111

594

1.87

8.95

1.0

1.1

1.07

1.14

u/l

0.49

264

Voice disturbances

104

545

1.92

8.95

1.0

1.1

1.01

1.09

u/l

1.15

247

Viral meningitis

3.50

8.94

1.2

1.0

1.13

1.04

u/l

0.41

Chronic diseases of tonsils and adenoids

325

1414

1.46

8.92

1.1

1.04

1.08

u/l

0.62

140

625

Disturbances of smell and taste

3.89

8.70

1.1

1.10

1.11

u/l

—

Systemic lupus erythematosus

3.60

8.70

1.1

1.01

1.08

u/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.98

8.61

1.4

1.0

1.59

1.14

u/l

0.73

Disorders of calcium metabolism

105

3.17

8.50

1.1

1.0

0.95

1.13

u/l

1.55

Unknown and unspecified causes of morbidity

105

3.16

8.49

1.2

1.0

1.04

1.13

u/l

0.41

Benign neoplasm of brain and other parts of central nervous system

121

3.00

8.46

1.1

0.99

1.17

u/l

1.59

Dentofacial anomalies [including malocclusion]

308

1718

1.44

8.43

1.1

1.02

1.08

u/l

1.07

141

735

Chronic rhinitis, nasopharyngitis and pharyngitis

131

752

1.75

8.42

1.1

1.14

1.05

u/l

0.54

319

Falls/tendency to fall

446

1633

1.37

8.35

1.1

1.03

1.07

u/l

0.67

200

720

Other enthesopathy of foot (+metatarsalgia)

178

2.60

8.32

1.0

1.1

1.01

1.15

u/l

1.45

Respiratory insufficiency

3.74

8.29

1.0

1.01

1.19

u/l

—

Anterior Iridocyclitis

455

1.97

8.28

1.2

1.1

1.08

1.07

u/l

0.01

212

Disorders of muscles

167

2.65

8.27

1.0

0.97

1.13

u/l

2.17

Septicaemia

130

698

1.75

8.27

1.1

1.21

1.03

u/l

2.17

314

Non-allergic asthma (mode)

305

2.18

8.25

1.0

0.99

1.07

u/l

1.24

135

Restless leg syndrome

264

2.29

8.23

1.1

1.03

1.11

u/l

0.82

132

Complications of procedures, not elsewhere classified

306

1768

1.43

8.19

1.1

1.04

1.08

u/l

0.49

141

807

Diarrhoea and gastroenteritis of presumed infectious origin

398

1906

1.38

8.18

1.1

1.07

u/l

0.02

181

848

SLE, strict definition

3.51

8.12

1.1

1.01

1.09

u/l

—

SLE, ICD10

3.51

8.12

1.1

1.01

1.09

u/l

—

Asthma, hospital admissions 3, pneumonia

118

663

1.78

8.12

1.1

1.12

1.06

u/l

0.28

298

Asthma-related pneumonia or sepsis

118

663

1.78

8.12

1.1

1.12

1.06

u/l

0.28

298

Metatarsalgia

163

2.65

8.11

1.0

1.1

1.02

1.15

u/l

1.14

Other disorders of bladder

169

2.62

8.08

1.2

1.1

0.99

1.09

u/l

0.79

Speech and linguistic disorders, excluding more controls

169

2.58

8.08

1.0

1.1

1.20

1.04

u/l

0.57

Acetic acid derivatives and related substances

104

280

1.93

8.08

1.1

1.06

1.11

u/l

0.25

103

Abnormal findings on examination of blood, without diagnosis

152

844

1.66

7.98

1.1

1.07

1.10

u/l

0.22

402

Other bacterial diseases

335

1599

1.41

7.92

1.1

1.14

1.06

u/l

1.47

168

713

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

126

2.88

7.90

1.0

1.1

1.09

1.17

u/l

0.28

All influenza

505

1.89

7.88

1.1

1.04

u/l

0.03

231

Asthma-related pneumonia

117

662

1.77

7.88

1.1

1.12

1.06

u/l

0.28

297

Zoster [herpes zoster]

160

971

1.63

7.87

1.2

1.1

1.09

1.08

u/l

0.10

433

Postviral fatigue syndrome

9.77

7.86

1.2

1.0

0.94

1.03

u/l

—

Asthma, hospital admissions , main diagnosis only

319

2003

1.41

7.77

1.1

1.00

1.08

u/l

2.01

142

892

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

218

1429

1.51

7.76

1.1

1.09

1.08

u/l

0.07

101

639

Non-allergic asthma (mode), excluding more controls

313

2.13

7.75

1.0

0.99

1.07

u/l

1.27

138

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

145

878

1.66

7.71

1.1

1.04

1.05

u/l

0.07

370

Other and unspecified degenerative diseases of nervous system

5.98

7.71

1.2

1.0

1.04

1.13

u/l

—

Deforming dorsopathies

510

1.87

7.66

1.0

1.1

1.03

1.06

u/l

0.25

220

Caries of dentine

475

1.89

7.65

1.1

1.02

1.07

u/l

0.41

234

Other disorders of ear

330

1539

1.41

7.65

1.1

1.10

1.08

u/l

0.23

146

704

Cluster headache, strict, including avohilmo

123

2.88

7.65

1.1

1.06

u/l

0.03

Dental caries

103

546

1.82

7.59

1.1

1.01

1.06

u/l

0.48

263

Diffuse large B-cell lymphoma, helper endpoint

3.62

7.58

1.3

1.1

1.14

1.16

u/l

0.08

Diffuse large B-cell lymphoma, including Hilmo

3.62

7.58

1.3

1.1

1.14

1.16

u/l

0.08

Diffuse large B-cell lymphoma

3.62

7.58

1.3

1.1

1.14

1.16

u/l

0.08

Soft tissue disorders related to use, overuse and pressure

463

1.91

7.55

1.1

1.08

u/l

0.01

218

Other/unspecified enthesopathies of lower limb, excluding foot

119

2.88

7.47

1.1

1.01

1.10

u/l

0.54

COPD/asthma related infections

407

1497

1.36

7.47

1.1

1.06

1.08

u/l

0.18

172

678

COPD/asthma/ILD related infections

407

1497

1.36

7.47

1.1

1.06

1.08

u/l

0.18

172

678

Specific development disorders of speech and language

120

2.83

7.41

1.0

1.1

1.29

0.99

u/l

1.01

Diseases of the skin and subcutaneous tissue

396

1456

1.37

7.37

1.1

1.04

1.08

u/l

0.53

167

671

Immunodeficiency with predominantly antibody defects

4.06

7.37

1.3

1.1

1.03

1.09

u/l

—

Other disorders of eyelid

122

680

1.71

7.31

1.1

1.11

1.09

u/l

0.12

327

Generalized anxiety disorder

434

1.92

7.29

1.1

0.97

1.08

u/l

1.17

184

Systemic lupus erythematosus, unspecified

3.43

7.27

1.0

1.1

1.03

1.07

u/l

—

Progressive vascular leukoencephalopathy

6.27

7.25

1.1

1.0

0.89

1.25

u/l

—

Other specified/unspecified necrotizing vasculopathies

7.47

7.24

1.1

1.0

1.16

1.15

u/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

201

1332

1.51

7.24

1.0

1.1

1.08

u/l

0.03

590

Cluster headache, wide,, including avohilmo

127

2.78

7.23

1.1

1.06

u/l

0.03

Other bacterial diseases

373

1738

1.36

7.19

1.1

1.15

1.06

u/l

1.55

180

774

Other septicaemia

113

627

1.74

7.16

1.1

1.15

1.04

u/l

1.65

287

Degenerative diseases of the nervous system

284

2.00

7.16

1.1

1.02

1.12

u/l

1.24

140

Early lumbar disc prolapse, operated

218

2.31

7.07

1.1

1.05

u/l

0.04

Disorders of conjunctiva

327

1908

1.38

7.00

1.1

1.04

1.07

u/l

0.32

144

840

Other and unspecified mononeuropathies of upper limb

3.89

7.00

1.2

1.1

1.06

1.16

u/l

0.60

Propionic acid derivatives

106

293

1.82

6.93

1.1

1.07

1.09

u/l

0.13

108

Other specified/unspecified systemic involvement of connective tissue

108

2.90

6.90

1.1

1.34

1.08

u/l

0.45

Pain and other conditions associated with female genital organs and menstrual cycle

110

587

1.73

6.81

1.1

1.05

1.01

u/l

0.40

244

Brain glioblastoma and astrocytoma

5.75

6.80

1.0

1.1

1.08

1.03

u/l

—

Other diseases of blood and blood-forming organs, wide

424

1.89

6.77

1.1

1.08

1.09

u/l

0.06

196

Hypokalaemia

191

2.37

6.77

1.2

1.0

0.98

1.10

u/l

1.44

Temporal arteritis

3.92

6.72

1.3

1.1

0.97

1.20

u/l

1.53

Giant cell arteritis with polymyalgia rheumatica

3.92

6.72

1.3

1.1

0.97

1.18

u/l

1.35

Other symptoms and signs involving the digestive system and abdomen

288

2.09

6.71

1.1

1.08

u/l

0.03

129

Mycoses

101

577

1.76

6.71

1.1

1.12

1.06

u/l

0.60

258

Influenza and pneumonia

407

1948

1.33

6.71

1.1

1.10

1.06

u/l

0.58

172

885

Acute upper respiratory infections of multiple and unspecified sites

298

1590

1.39

6.70

1.1

0.97

1.09

u/l

4.09

131

709

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

138

847

1.62

6.69

1.1

0.95

1.04

u/l

2.90

364

Use of pramipexole

370

1.95

6.68

1.1

0.99

1.09

u/l

1.45

184

Acute and subacute iridocyclitis

427

1.88

6.64

1.2

1.1

1.08

1.07

u/l

0.04

194

Hypothyroidism, strict autoimmune, 3 medication purchases required

316

1552

1.38

6.59

1.1

1.11

1.03

u/l

1.20

146

665

Other metabolic disorders

297

2.06

6.59

1.2

1.1

0.99

1.08

u/l

0.98

125

337

1495

1.37

6.58

1.1

1.13

1.08

u/l

0.48

140

676

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

337

1495

1.37

6.58

1.1

1.13

1.08

u/l

0.48

140

676

Other diseases of the respiratory system

304

2.05

6.56

1.0

1.1

0.98

1.11

u/l

2.08

148

Other respiratory disorders and diseases

304

2.05

6.56

1.0

1.1

0.98

1.11

u/l

2.08

148

Giant cell arteritis

3.53

6.44

1.3

1.1

0.99

1.17

u/l

1.38

Hypermetropia

141

2.57

6.43

1.1

1.01

1.11

u/l

0.59

Genitourinary diseases

232

797

1.46

6.39

1.1

1.03

1.08

u/l

0.39

111

372

Behavioural syndromes associated with physiological disturbances and physical factors

359

1902

1.34

6.37

1.1

1.08

1.06

u/l

0.14

147

867

Disorders of pituitary gland, other and/or unspecified

11.51

6.37

1.3

1.1

1.02

u/l

—

Other and unspecified hydrocephalus

5.59

6.33

1.2

1.0

1.69

1.10

u/l

—

Dystonia

108

2.80

6.32

1.0

1.1

1.03

1.08

u/l

0.30

Urticaria and erythema

151

973

1.56

6.30

1.1

1.15

1.04

u/l

0.68

431

Injury, poisoning and certain other consequences of external causes

227

780

1.46

6.25

1.1

1.06

1.09

u/l

0.22

105

333

Infections with a predominantly sexual mode of transmission

194

1228

1.48

6.24

1.1

1.00

1.04

u/l

0.59

528

Any dementia, excluding more controls

279

1.90

6.23

1.1

1.07

1.10

u/l

0.13

134

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

182

761

1.51

6.22

1.1

1.04

1.08

u/l

0.31

332

Tinnitus

480

1.80

6.22

1.1

1.08

1.06

u/l

0.12

224

Injuries to the wrist and hand

383

2009

1.32

6.19

1.1

1.03

1.07

u/l

0.63

166

905

Persistent mood disorders

402

1.87

6.18

1.1

1.02

1.08

u/l

0.44

182

Hereditary ataxia

7.82

6.16

1.0

1.1

0.97

0.98

u/l

—

Other and unspecified coagulation defects

116

2.70

6.09

1.1

1.00

1.07

u/l

0.62

Polyarteritis nodosa and related conditions

6.81

6.07

1.0

1.09

1.11

u/l

—

Conjunctivitis

299

1836

1.36

6.07

1.1

1.01

1.07

u/l

1.17

129

803

Sleep disorders

346

1874

1.34

6.06

1.1

1.06

u/l

0.01

137

855

Spondylolisthesis/Spondylolysis

280

2.04

6.04

1.0

1.1

1.05

1.10

u/l

0.28

132

Disorders of adult personality and behaviour

136

868

1.57

5.95

1.1

1.05

1.03

u/l

0.19

373

Intestinal infectious diseases

430

1893

1.30

5.94

1.1

1.07

u/l

0.02

193

847

Spondyloarthritis

337

1.94

5.93

1.1

1.28

1.08

u/l

0.65

169

420

1666

1.30

5.87

1.1

1.00

1.10

u/l

2.16

182

758

Herpesviral [herpes simplex] infections

250

2.09

5.86

1.2

1.1

1.08

1.12

u/l

0.14

122

Disorders of lens

200

854

1.46

5.85

1.1

1.03

1.11

u/l

1.03

442

Raynaud syndrome

205

2.21

5.81

1.0

1.1

1.00

1.12

u/l

1.24

Injuries to the ankle and foot

288

1888

1.36

5.80

1.1

1.00

1.07

u/l

1.50

125

834

Trochanteric bursitis

218

2.16

5.79

1.0

1.1

1.05

1.16

u/l

1.10

109

Astigmatism

119

2.62

5.78

1.1

0.96

1.06

u/l

1.06

Cardiac arrhythmias

242

1119

1.41

5.78

1.1

1.03

1.08

u/l

0.65

109

500

Alzheimer’s disease (Early onset)

3.62

5.76

1.2

1.0

1.00

1.24

u/l

1.11

Other specified/unspecified inflammatory spondylopathies

2.93

5.73

1.1

1.43

1.08

u/l

—

Bronchitis

403

1954

1.30

5.73

1.1

0.99

1.08

u/l

2.21

172

887

Other disorders of bone

478

1.76

5.73

1.0

1.1

1.08

1.06

u/l

0.14

217

Exposure to unspecified factor

373

2051

1.31

5.73

1.1

1.05

1.07

u/l

0.21

176

911

Cauda equina syndrome

5.70

5.72

1.1

1.0

1.04

1.13

u/l

—

Other skin changes

286

2.00

5.72

1.1

1.05

1.11

u/l

0.27

139

Disorders of speech understanding and production

3.01

5.72

1.0

1.33

0.99

u/l

0.80

Postprocedural endocrine and metabolic disorders, not elsewhere classified

273

2.02

5.70

1.2

1.0

0.94

1.09

u/l

2.31

115

Other viral diseases

164

1093

1.49

5.69

1.1

0.99

1.05

u/l

1.31

461

Glaucoma suspect

103

622

1.66

5.66

1.1

1.04

1.08

u/l

0.44

299

Speech and linguistic disorders

205

2.17

5.63

1.0

1.1

1.20

0.98

u/l

0.91

Dementia, including avohilmo

102

416

1.69

5.62

1.1

1.08

1.07

u/l

0.10

211

Unspecified/other endometriosis

289

1.98

5.59

1.0

1.1

0.87

1.00

u/l

4.66

110

Persons with potential health hazards related to communicable diseases

176

1194

1.46

5.56

1.1

1.03

1.04

u/l

0.16

512

Paroxysmal tachycardia

383

1.77

5.51

1.1

1.05

1.14

u/l

0.43

178

Chronic iridocyclitis

105

2.69

5.50

1.2

1.1

1.25

1.06

u/l

0.34

Anti-inflammatory and antirheumatic products, non-steroids

100

293

1.72

5.49

1.1

1.03

1.09

u/l

0.47

108

Diseases of salivary glands

117

736

1.59

5.48

1.1

1.06

1.07

u/l

0.01

333

Fungal Sepsis

3.25

5.45

1.3

1.0

1.17

1.13

u/l

—

Inflammatory diseases of female pelvic organs

249

1328

1.38

5.45

1.0

1.1

1.08

1.05

u/l

0.27

573

Anosmia

9.80

5.43

1.2

1.1

1.18

1.04

u/l

—

Insomnia

339

1879

1.32

5.42

1.1

1.07

u/l

0.07

132

850

Paracetamol or NSAID medication

167

1.97

5.40

1.0

1.07

1.10

u/l

0.08

Other specified disorders of muscle

3.76

5.38

1.1

1.0

0.99

1.08

u/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

268

1785

1.35

5.36

1.1

1.06

1.05

u/l

0.03

123

797

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

2.88

5.36

1.2

1.1

0.92

1.10

u/l

—

Vertical strabismus

3.12

5.35

1.1

1.11

1.07

u/l

—

Pneumonia, organism unspecified

323

1713

1.32

5.34

1.1

1.15

1.05

u/l

1.29

136

781

Meralgia paraesthetica

3.31

5.31

1.0

1.1

1.10

1.07

u/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

2.54

5.29

1.2

1.1

1.26

1.08

u/l

0.28

Candidiasis

111

696

1.60

5.29

1.2

1.1

1.07

1.05

u/l

0.21

302

Other symptoms and signs involving the circulatory and respiratory systems

125

2.50

5.28

1.1

1.05

1.13

u/l

0.55

Acute bronchitis

132

844

1.54

5.28

1.1

1.06

1.05

u/l

0.06

378

Transport accidents

178

1058

1.45

5.27

1.0

1.1

1.03

1.08

u/l

0.42

470

Brain glioblastoma

5.51

5.26

1.0

1.11

1.04

u/l

—

Benign neoplasm of other and unspecified endocrine glands

261

2.00

5.26

1.1

1.20

1.11

u/l

0.22

135

Other specified/unspecified soft tissue disorders

3.15

5.19

1.0

1.04

1.15

u/l

—

Oxicams

230

1.83

5.18

1.1

1.11

1.13

u/l

0.09

Personality disorders

126

818

1.55

5.18

1.1

1.03

u/l

0.05

353

Other peripheral vascular diseases

164

2.27

5.14

1.1

1.04

1.13

u/l

0.73

Bacterial pneumonia, not elsewhere classified

119

670

1.57

5.13

1.1

1.18

1.04

u/l

0.98

312

Urticaria

124

804

1.55

5.13

1.1

1.19

1.06

u/l

0.64

355

Keratitis

131

860

1.53

5.12

1.0

1.1

1.06

1.05

u/l

0.10

379

Injuries to the knee and lower leg

444

1947

1.27

5.10

1.1

1.05

1.07

u/l

0.19

208

859

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

179

785

1.45

5.09

1.0

1.1

0.99

1.00

u/l

0.11

298

Alzheimer’s disease (Late onset), excluding more controls

3.58

5.05

1.3

1.1

1.07

1.32

u/l

—

Chronic laryngitis and laryngotracheitis

238

2.02

5.03

1.1

1.23

1.14

u/l

0.18

108

Dermatographic urticaria

166

2.25

5.01

1.1

1.09

1.10

u/l

0.01

Other disorders of skin and subcutaneous tissue

216

1388

1.38

4.99

1.1

1.08

u/l

0.01

636

Other obstetric conditions, not elsewhere classified

183

811

1.44

4.98

1.0

1.1

1.01

1.00

u/l

0.13

309

Persons encountering health services in other circumstances

143

957

1.49

4.98

1.1

0.99

1.04

u/l

0.63

430

Bacterial pneumoniae

126

725

1.53

4.97

1.1

1.17

1.04

u/l

1.00

337

Disorders of skin appendages

190

1349

1.41

4.95

1.1

0.99

1.05

u/l

0.96

585

Disorders of orbit

2.75

4.95

1.1

0.97

1.07

u/l

—

Pulmonary heart disease

479

1.69

4.88

1.2

1.1

1.04

1.09

u/l

0.45

222

Asthma/COPD (KELA code 203)

355

1892

1.29

4.84

1.1

1.02

1.08

u/l

1.35

152

856

Pulmonary embolism

481

1.69

4.81

1.2

1.1

1.04

1.09

u/l

0.42

222

Implicit fungal Sepsis

3.09

4.80

1.3

1.0

1.17

1.13

u/l

—

Polymyalgia rheumatica

169

2.20

4.80

1.1

1.03

1.16

u/l

1.20

Fenamates

188

1.95

4.79

1.1

1.00

1.16

u/l

1.26

Bacterial pneumonia (organism specified)

132

797

1.50

4.78

1.1

1.18

1.05

u/l

0.98

365

3.20

4.78

1.0

1.1

1.00

1.07

u/l

—

Myositis

3.61

4.78

1.0

0.99

1.28

u/l

—

Specific personality disorders

109

699

1.56

4.77

1.1

0.99

1.03

u/l

0.60

302

Autoimmune thyroiditis

3.46

4.77

1.3

1.0

0.90

1.11

u/l

—

Irregular menses

214

1228

1.38

4.76

1.1

0.97

1.06

u/l

2.95

507

Other viral diseases

124

816

1.52

4.76

1.1

0.98

1.04

u/l

0.95

361

Herpesviral [herpes simplex] infections

102

645

1.59

4.74

1.1

1.11

1.06

u/l

0.23

278

Persons encountering health services for specific procedures, not carried out

177

2.16

4.71

1.1

1.12

1.08

u/l

—

Procreative management

145

822

1.47

4.70

1.1

1.03

1.07

u/l

0.55

359

Injuries to the head

410

1999

1.26

4.69

1.1

1.07

1.06

u/l

0.05

189

892

Osteoporosis with pathological fracture (FG)

2.72

4.67

1.3

1.1

1.03

1.05

u/l

0.08

Infections with a predominantly sexual mode of transmission

145

991

1.47

4.67

1.1

1.02

u/l

0.02

431

Ovarian cyst

159

628

1.46

4.67

1.1

1.01

1.04

u/l

0.37

266

Intestinal infectious diseases

345

2042

1.28

4.67

1.1

1.05

1.07

u/l

0.23

161

908

Diseases of pulp and periapical tissues, including avohilmo

389

1583

1.27

4.67

1.1

1.03

1.09

u/l

1.10

154

715

Other peripheral vertigo

165

2.19

4.65

1.2

1.0

1.06

1.11

u/l

0.32

Dementia

381

1.65

4.64

1.1

1.08

1.07

u/l

0.07

197

Any death

168

840

1.43

4.63

1.1

1.41

1.05

u/l

1.00

418

Injuries to the neck

595

1.60

4.61

1.1

1.01

1.05

u/l

0.54

268

Other heart diseases, wide

361

1728

1.28

4.60

1.1

1.05

1.08

u/l

0.34

165

784

Use of amantadine

4.60

4.58

1.0

1.1

1.25

1.14

u/l

—

Deviated nasal septum

104

666

1.56

4.57

1.1

1.01

1.13

u/l

1.25

321

Faecal incontinence

128

2.35

4.57

1.3

1.1

0.98

1.11

u/l

0.61

Ankylosing spondylitis

147

2.26

4.56

1.1

1.45

1.06

u/l

0.66

Episcleritis

116

2.43

4.55

1.0

1.1

1.05

u/l

0.02

Phobic anxiety disorders

340

1.80

4.53

1.1

0.95

1.05

u/l

2.08

153

Coagulation defects, purpura and other haemorrhagic conditions

422

1.71

4.52

1.1

1.04

1.09

u/l

0.64

187

Other and unspecified trigeminal disorders

4.90

4.52

1.1

0.97

1.15

u/l

—

Benign neoplasm of colon, rectum, anus and anal canal

169

1037

1.42

4.50

1.2

1.1

1.19

1.09

u/l

0.25

497

Arthropathies in other diseases classified elsewhere

2.88

4.50

1.5

1.1

1.39

1.11

u/l

—

Other symptoms and signs involving general sensations and perceptions

3.17

4.49

1.1

1.0

1.00

1.12

u/l

—

Other complications of surgical and medical care, not elsewhere classified

194

2.07

4.49

1.2

1.1

0.95

1.13

u/l

2.40

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

355

1902

1.27

4.49

1.1

1.14

1.06

u/l

1.08

150

864

Scleritis and episcleritis

136

2.30

4.45

1.0

1.1

1.04

1.07

u/l

0.11

Intracerebral haemorrhage

136

2.29

4.44

1.0

1.1

1.08

1.17

u/l

0.47

Poisoning by drugs, medicaments and biological substances

104

672

1.55

4.43

1.1

1.06

1.04

u/l

0.16

300

Other diseases of pleura

114

656

1.53

4.43

1.0

1.1

1.12

1.05

u/l

0.51

312

Presence of other functional implants

153

735

1.45

4.40

1.2

1.1

1.08

u/l

0.00

362

Medial epicondylitis

3.02

4.40

1.1

1.14

1.10

u/l

—

Vestibular neuronitis

169

2.14

4.40

1.0

1.1

1.24

1.11

u/l

0.18

Vascular dementia

2.84

4.40

1.0

1.36

1.23

u/l

—

Bacterial meningitis

2.84

4.40

1.0

1.1

1.18

1.07

u/l

—

Other arrhythmias

231

1299

1.34

4.38

1.1

1.04

1.08

u/l

0.54

103

591

Nonorganic sleeping disorders

557

1.60

4.36

1.1

1.02

1.06

u/l

0.39

250

Osteoporosis

363

1.73

4.34

1.2

1.1

1.15

1.10

u/l

0.13

179

Exclusions for E4_PCOS_CONSORTIUM

288

1384

1.30

4.33

1.1

1.05

1.04

u/l

0.06

135

591

Diabetes insipidus

6.40

4.32

1.0

1.1

1.72

1.02

u/l

—

Conjunctivitis (acute, non atopic)

105

682

1.54

4.31

1.1

1.05

u/l

0.03

300

Other retinal disorders

173

962

1.40

4.31

1.1

1.05

1.09

u/l

0.48

466

Other nutritional deficiencies

253

1813

1.32

4.29

1.1

1.17

1.05

u/l

0.36

107

808

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

191

2.05

4.28

1.2

1.1

1.04

1.13

u/l

0.51

Mycoses

309

2100

1.28

4.25

1.1

1.02

1.07

u/l

1.31

148

930

Other coagulation defects

165

2.13

4.24

1.1

1.00

1.06

u/l

0.60

Other and unspecified myopathies

139

2.24

4.24

1.2

1.1

1.33

1.20

u/l

0.15

Reimbursement for rheumatic diseases

191

1393

1.37

4.23

1.1

1.14

1.06

u/l

0.62

628

Attention to artificial openings

3.16

4.21

1.2

1.0

0.89

1.11

u/l

—

Disorders of vitreous body

136

907

1.45

4.20

1.1

1.01

1.09

u/l

2.08

437

Panhypopituitarism

4.87

4.20

1.2

1.0

1.53

1.11

u/l

—

Any dementia

321

1.67

4.19

1.1

1.07

1.10

u/l

0.12

166

Conductive and sensorineural hearing loss

229

1156

1.34

4.18

1.1

1.11

1.09

u/l

0.14

109

557

Hyperkinetic disorders, excluding more controls

299

1.80

4.17

1.0

1.1

0.95

1.00

u/l

0.58

118

Retinal vascular occlusion

160

2.13

4.14

1.1

0.98

1.18

u/l

1.94

Retinal vascular disorders

160

2.13

4.14

1.1

0.98

1.18

u/l

1.94

Hypogonadotropic hypogonadism

3.01

4.13

1.2

1.1

1.10

1.02

u/l

—

Covid-19 suspected case

589

1.57

4.12

1.1

1.07

1.03

u/l

0.22

244

Pulmonary heart disease, diseases of pulmonary circulation

526

1.60

4.11

1.2

1.1

1.05

1.08

u/l

0.26

245

Other disorders of binocular vision

4.70

4.08

1.1

0.95

1.18

u/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

4.69

4.07

1.0

0.98

1.11

u/l

—

Other abnormal immunological findings in serum

3.38

4.06

1.0

1.1

0.97

1.10

u/l

—

Psychotic depression

2.57

4.05

1.0

1.54

1.20

u/l

—

Disorders of vitreous body and globe

138

928

1.43

3.98

1.1

1.01

1.08

u/l

2.04

446

Calcific tendinitis of shoulder

2.49

3.96

1.0

1.02

1.11

u/l

0.64

All pneumoniae

364

1948

1.25

3.96

1.1

1.13

1.06

u/l

1.05

154

887

Statin medication

278

1207

1.30

3.96

1.1

1.13

1.05

u/l

0.81

127

538

Spondylopathies (FG)

334

1.74

3.93

1.1

1.32

1.04

u/l

0.84

145

Benign neoplasm: Colon

137

918

1.43

3.91

1.2

1.1

1.22

1.10

u/l

0.26

448

Glaucoma

142

862

1.42

3.88

1.1

1.09

1.08

u/l

0.09

425

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

158

1136

1.39

3.86

1.1

1.00

1.05

u/l

0.80

486

Emotionally unstable personality disorder

382

1.68

3.83

1.1

0.98

1.03

u/l

0.48

166

Circumscribed brain atrophy

4.34

3.83

1.0

1.00

1.12

u/l

—

Pneumonias (Asthma/COPD co-morbidities)

360

1942

1.25

3.82

1.1

1.14

1.06

u/l

1.06

151

887

Diabetic neuropathy

158

2.09

3.82

1.1

0.91

1.05

u/l

2.45

Social phobias

228

1.89

3.81

1.0

1.1

0.93

1.02

u/l

1.75

Injuries to the thorax

134

942

1.42

3.81

1.1

1.01

1.10

u/l

1.16

441

Drug-induced cataract

3.73

3.80

1.3

1.0

0.93

1.13

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

102

682

1.50

3.78

1.1

1.00

1.03

u/l

0.28

285

Aneurysms, operations, SAH

250

1.85

3.78

1.0

1.1

1.14

1.12

u/l

0.06

130

Continuous positive airway pressure

264

1.76

3.77

1.1

1.74

1.09

u/l

0.44

141

Thyroiditis, ILD-related definition

222

1.90

3.76

1.1

1.02

1.08

u/l

0.35

114

Plantar fascial fibromatosis

160

2.07

3.76

1.1

1.05

1.14

u/l

0.59

Secondary hypertension

119

2.25

3.76

1.0

1.1

1.00

1.07

u/l

—

Contact with and exposure to communicable diseases

141

1000

1.41

3.75

1.1

0.98

1.02

u/l

0.60

431

Other/unspecified disorders of vestibular function

2.66

3.73

1.1

1.0

1.06

1.10

u/l

—

Sensorineural hearing loss

209

1068

1.33

3.72

1.1

1.10

u/l

0.02

514

Rash and other nonspecific skin eruption

168

2.03

3.69

1.0

1.00

1.11

u/l

0.58

Focal brain injury

5.01

3.68

1.2

1.0

0.94

1.31

u/l

—

Need for other prophylactic measures

122

2.23

3.67

1.2

1.1

1.27

1.16

u/l

0.40

Acute tubulo-interstitial nephritis

203

1323

1.33

3.66

1.1

1.04

1.05

u/l

0.14

588

Poisoning by medicine

623

1.51

3.65

1.1

1.06

1.04

u/l

0.13

277

Polyarthropathies

233

1166

1.31

3.65

1.1

1.15

1.08

u/l

0.55

106

516

Obstructive hydrocephalus

4.46

3.64

1.2

1.0

1.45

1.10

u/l

—

Obsessive-compulsive disorder

183

1.98

3.63

1.1

1.01

1.03

u/l

0.10

Asthma and allergy

316

1.72

3.61

1.1

1.0

0.90

1.06

u/l

2.55

127

Other problems related to primary support group, including family circumstances

297

1.74

3.61

1.1

0.95

1.02

u/l

0.88

133

Sicca syndrome [Sjögren]

156

2.06

3.61

1.1

1.18

1.11

u/l

0.20

Nontraumatic intracranial haemmorrhage

254

1.81

3.60

1.0

1.1

1.14

1.10

u/l

0.20

133

Endometriosis

144

600

1.41

3.59

1.0

1.1

1.01

1.04

u/l

0.18

252

Other and unspecified disorders of vitreous body

108

729

1.46

3.57

1.1

1.02

1.09

u/l

1.59

364

Other diseases of anus and rectum

561

1.53

3.56

1.1

1.01

1.07

u/l

1.01

266

Divergent concomitant strabismus

157

2.05

3.55

1.1

1.07

1.10

u/l

0.10

Allergic asthma (mode)

566

1.52

3.55

1.1

1.0

0.93

1.05

u/l

3.15

224

Allergic asthma (mode), excluding more controls

568

1.52

3.50

1.1

1.0

0.93

1.05

u/l

3.15

224

Venous thromboembolism

146

1024

1.38

3.48

1.1

1.04

1.10

u/l

0.65

492

Other arthrosis

157

793

1.37

3.47

1.1

1.06

1.12

u/l

0.55

375

Otalgia

166

2.00

3.44

1.1

1.06

1.10

u/l

—

Diseases of pulp and periapical tissues and dental caries

218

851

1.31

3.42

1.1

1.07

1.09

u/l

0.19

103

404

Horner syndrome

4.15

3.41

1.1

1.0

1.15

u/l

—

Patent foramen ovale

3.13

3.38

1.0

0.94

1.05

u/l

—

Dermatophytosis

231

1.82

3.36

1.1

1.13

1.11

u/l

0.10

125

Asthma and allergy, excluding more controls

323

1.69

3.36

1.1

1.0

0.90

1.07

u/l

2.75

129

Vasomotor and allergic rhinitis

143

1023

1.37

3.35

1.1

1.00

1.08

u/l

0.96

430

Appendectomy

243

1826

1.27

3.34

1.1

1.04

1.07

u/l

0.31

828

Other specified/unspecified hearing loss

134

2.10

3.33

1.1

1.17

1.16

u/l

0.02

Localized swelling, mass and lump of skin and subcutaneous tissue

580

1.50

3.32

1.1

1.08

1.06

u/l

0.15

270

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.94

3.30

1.1

1.0

1.09

1.08

u/l

—

Congenital malformations, deformations and chromosomal abnormalities

250

1819

1.27

3.29

1.1

1.06

u/l

0.07

118

777

Retinal breaks without detachment

277

1.74

3.29

1.1

0.98

1.11

u/l

2.41

142

Problems related to lifestyle

233

1.81

3.28

1.1

0.95

1.03

u/l

0.99

111

Menorrhagia

138

549

1.40

3.28

1.1

1.09

1.05

u/l

0.28

227

Dislocation, sprain and strain of joints and ligaments at neck level

423

1.59

3.27

1.0

1.1

1.03

1.05

u/l

0.23

185

Sequelae of external causes of morbidity and mortality

510

1.53

3.26

1.1

1.09

1.08

u/l

0.05

236

Infections of the skin and subcutaneous tissue

202

1542

1.30

3.26

1.1

0.99

1.07

u/l

1.51

694

Other specified and unspecified retinal disorders

2.60

3.22

1.4

1.1

0.99

1.23

u/l

—

Diseases of appendix

270

1945

1.25

3.21

1.1

1.05

1.08

u/l

0.19

118

883

Disorders of psychological development

307

1.67

3.21

1.0

1.1

1.17

0.98

u/l

0.86

132

DVT of lower extremities and pulmonary embolism

109

762

1.43

3.20

1.1

1.05

1.06

u/l

0.06

359

Cerebral aneurysm, nonruptured

150

2.01

3.19

1.0

1.1

1.06

1.13

u/l

—

Malignant neoplasm of breast, including Hilmo

681

0.65

3.19

1.0

1.1

1.10

1.06

u/l

0.19

293

Malignant neoplasm of breast, HER2-negative, including Hilmo

681

0.65

3.19

1.0

1.1

1.10

1.06

u/l

0.19

293

Chronic apical periodontitis

406

1917

1.21

3.19

1.1

1.03

1.07

u/l

0.80

174

866

Congenital malformations, deformations and chromosomal abnormalities

232

1738

1.27

3.18

1.1

1.06

u/l

0.02

107

744

Other CVD (FINNGEN)

125

1.99

3.18

1.2

1.1

1.33

1.11

u/l

0.38

Senile cataract

158

717

1.35

3.14

1.1

1.08

1.12

u/l

0.23

374

Complications of other internal prosthetic devices, implants and grafts

2.64

3.13

1.2

1.1

1.42

1.22

u/l

—

Abnormal results of function studies

165

1.95

3.13

1.0

1.1

0.94

1.12

u/l

2.19

Internal derangement of knee

124

890

1.39

3.13

1.0

1.1

0.96

1.09

u/l

2.28

403

Other acute lower respiratory infections

166

1193

1.33

3.13

1.1

1.03

1.08

u/l

0.34

543

Other viral diseases, not elsewhere classified

103

716

1.43

3.11

1.1

1.03

1.04

u/l

0.20

321

Other and unspecified mood [affective] disorders

187

1.88

3.10

1.1

1.0

0.96

1.04

u/l

0.94

Other cataract

112

598

1.42

3.09

1.1

1.01

1.06

u/l

0.80

312

Disorders of synovium and tendon in diseases classified elsewhere

3.70

3.09

1.0

0.90

1.13

u/l

—

Presbyopia

125

2.09

3.08

1.0

1.1

0.97

1.10

u/l

1.57

Diseases of oral cavity, salivary glands and jaws

187

730

1.32

3.07

1.1

1.07

1.08

u/l

0.06

345

Convergent concomitant strabismus

132

2.06

3.07

1.1

1.09

1.04

u/l

0.16

All kidney diseases

347

1951

1.22

3.05

1.1

1.09

1.06

u/l

0.25

144

893

Unspecified fall

153

1129

1.34

3.05

1.1

1.04

1.08

u/l

0.27

515

Appendicitis, broad definition

267

1942

1.24

3.04

1.1

1.06

1.08

u/l

0.17

117

882

Immunodeficiencies

106

2.18

3.03

1.3

1.1

1.04

1.07

u/l

—

Short Achilles tendon (acquired)

2.91

3.03

1.1

0.98

1.04

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

552

1.49

3.03

1.0

1.1

1.03

1.04

u/l

0.08

222

Exposure to other specified factors

269

1990

1.24

3.01

1.1

0.97

1.08

u/l

3.82

112

896

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

607

1.44

3.00

1.1

1.06

1.00

u/l

0.31

246

Congenital malformations of the nervous system

2.77

2.99

1.0

1.1

1.25

1.07

u/l

—

Hypercalcemia

2.42

2.97

1.0

1.1

0.94

1.23

u/l

—

Meniscus derangement

171

874

1.32

2.97

1.1

1.02

1.11

u/l

0.95

404

Sleep disorders, other/unspecified

2.29

2.94

1.1

1.0

0.99

1.08

u/l

—

Brain meningioma, including Hilmo

2.29

2.94

1.1

2.27

1.07

u/l

0.41

Fibroblastic disorders

333

1.62

2.93

1.1

1.04

1.11

u/l

0.71

165

Autoimmune hyperthyroidism

101

2.19

2.93

1.3

1.0

1.20

1.04

u/l

—

Abnormal weight loss

170

1.89

2.90

1.2

1.1

1.16

1.15

u/l

0.05

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

206

1575

1.27

2.88

1.1

1.00

1.06

u/l

1.34

690

Substance abuse, excluding more controls

165

1073

1.31

2.87

1.1

1.10

u/l

0.02

502

Other hearing loss

389

1.56

2.86

1.1

1.12

1.08

u/l

0.19

189

Bipolar affective disorders

486

1.51

2.86

1.0

1.1

0.94

1.05

u/l

2.95

208

Other bacterial intestinal infections

470

1.51

2.85

1.1

1.07

1.06

u/l

0.07

215

Other pleural conditions

129

2.02

2.85

1.0

1.16

1.21

u/l

0.10

Other and unspecified anaemias

666

1.42

2.85

1.1

1.18

1.05

u/l

0.82

321

Secondary and unspecified malignant neoplasm of lymph nodes

136

1.99

2.85

1.1

1.13

1.10

u/l

0.07

Endometriosis of pelvic peritoneum

448

1.51

2.84

1.0

1.1

0.93

1.03

u/l

1.47

178

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

341

1838

1.21

2.83

1.1

1.14

1.05

u/l

0.43

165

821

Dental caries, including avohilmo

234

948

1.26

2.81

1.1

1.07

1.08

u/l

0.04

103

455

Benign neoplasm: Skin of lower limb, including hip

2.66

2.80

1.0

1.1

0.90

1.09

u/l

—

Acute lymphadenitis

151

1.93

2.80

1.2

1.1

0.95

1.05

u/l

1.13

Diseases of external ear

103

736

1.40

2.80

1.0

1.1

0.98

1.05

u/l

1.57

331

Fracture of foot, except ankle

628

1.44

2.79

1.1

1.05

u/l

0.01

280

Caries of dentine, including avohilmo

255

1044

1.25

2.78

1.1

1.05

1.08

u/l

0.39

110

495

Malignant neoplasm of breast, HER2-negative

642

0.66

2.77

1.0

1.1

1.09

1.06

u/l

0.14

280

Hyperlipidaemia, other/unspecified

578

1.44

2.76

1.1

1.09

1.11

u/l

0.13

284

Other noninflammatory disorders of vulva and perineum

217

1.76

2.75

1.1

1.04

1.06

u/l

0.10

Status post-ami

304

0.48

2.75

1.0

1.1

1.37

1.09

u/l

—

166

Necrosis of pulp, including avohilmo

213

1689

1.26

2.75

1.1

1.06

1.08

u/l

0.10

760

Excessive vomiting in pregnancy

240

1.72

2.73

1.1

1.00

1.06

u/l

0.43

Ganglion

435

1.52

2.72

1.1

0.97

1.09

u/l

2.20

192

Complications of genitourinary prosthetic devices, implants and grafts

2.73

2.72

1.1

1.04

1.10

u/l

—

All influenza (not pneumonia)

317

1.61

2.71

1.1

1.10

1.04

u/l

0.15

156

Hodgkin lymphoma, hilmo

2.52

2.71

1.2

1.0

1.26

1.04

u/l

—

Other and unspecified erythematous conditions

2.52

2.70

1.1

1.02

1.11

u/l

—

Use of anticholinesterases

291

1.57

2.70

1.1

1.05

1.11

u/l

0.65

141

N06DA Anticholinesterases

291

1.57

2.70

1.1

1.05

1.11

u/l

0.65

141

Unspecified haematuria

102

605

1.40

2.69

1.1

1.08

1.06

u/l

0.08

289

Tonsillectomy and adenotomy

248

1393

1.24

2.69

1.1

0.99

1.04

u/l

0.94

115

583

Other anaemias

672

1.40

2.69

1.1

1.18

1.05

u/l

0.80

323

Early onset COPD, excluding more controls

279

1.65

2.68

1.2

1.0

0.98

1.15

u/l

0.84

138

Acute appendicitis, no complications

207

1640

1.26

2.66

1.0

1.1

1.03

1.07

u/l

0.39

735

Fracture of rib(s), sternum and thoracic spine

544

1.45

2.64

1.1

1.00

1.06

u/l

0.67

254

Separation of retinal layers (serosa)

2.22

2.64

1.1

0.98

1.12

u/l

1.02

Malignant neoplasm of breast

656

0.68

2.63

1.0

1.1

1.09

1.06

u/l

0.14

283

Other congenital malformations of circulatory system

2.68

2.63

1.0

1.1

1.05

1.09

u/l

—

Sacroiliitis, not elsewhere classified

106

2.09

2.63

1.2

1.1

1.28

1.05

u/l

—

Other and unspecified epidermal thickening

2.67

2.63

1.1

1.0

0.96

1.07

u/l

—

Hypocalcemia

2.95

2.62

1.3

1.0

0.96

1.13

u/l

—

Varicella [chickenpox]

106

2.08

2.62

1.0

1.1

1.18

1.09

u/l

0.20

Memory loss

134

1.95

2.60

1.5

1.0

0.97

1.19

u/l

1.91

Acute appendicitis

250

1904

1.23

2.59

1.1

1.06

1.08

u/l

0.13

113

866

Adhesive capsulitis of shoulder

244

1.68

2.58

1.0

1.1

1.01

1.13

u/l

1.32

128

Brain meningioma

2.20

2.57

1.1

0.95

1.08

u/l

1.47

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.37

2.56

1.0

1.1

1.07

1.05

u/l

—

Type 2 diabetes, wide definition

234

1207

1.24

2.56

1.1

1.10

u/l

0.04

111

574

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

217

1378

1.25

2.55

1.1

1.02

1.06

u/l

0.68

589

Chronic gastritis

434

1.50

2.55

1.0

1.1

1.17

1.09

u/l

0.24

205

Emotional disorders starting during childhood or adolecense, excluding more controls

2.10

2.55

1.1

0.92

1.00

u/l

—

Sequelae with surgical and medical care as external cause

370

1.54

2.54

1.1

1.00

1.10

u/l

1.52

176

Ischemic heart diseases

242

1175

1.24

2.54

1.0

1.1

1.04

1.11

u/l

0.96

119

579

Anomalies of pupillary function

2.63

2.54

1.0

1.1

1.15

1.10

u/l

—

Secondary uncertain malignant neoplasm

193

1.77

2.53

1.1

1.28

1.07

u/l

0.43

Acute pharyngitis

407

1.51

2.53

1.1

0.98

1.04

u/l

0.66

190

Endometriosis of rectovaginal septum and vagina

164

1.84

2.53

1.0

1.1

1.01

1.03

u/l

—

Diseases of liver

717

1.38

2.52

1.1

1.12

1.06

u/l

0.30

337

Adrenocortical insufficiency

2.28

2.51

1.5

1.1

1.15

1.03

u/l

0.44

Unspecified abortion

122

1.98

2.50

1.0

1.10

1.04

u/l

0.21

Inflammatory disease of uterus

412

1.51

2.50

1.0

1.1

1.12

1.04

u/l

0.19

169

Single delivery by caesarean section

405

0.62

2.50

1.0

1.1

1.01

1.04

u/l

0.22

152

Monoamine oxidase A inhibitors

194

1.76

2.50

1.1

1.07

1.14

u/l

0.34

Rosacea

270

1.64

2.49

1.0

0.92

1.12

u/l

4.63

127

Cholecystectomy

215

1493

1.24

2.48

1.1

1.17

1.08

u/l

0.74

673

Disturbance of activity and attention

357

1.54

2.48

1.0

1.1

0.95

0.98

u/l

0.34

150

Endometriosis diagnosis and infertility diagnosis occurring together

325

1.58

2.48

1.0

1.1

0.87

1.03

u/l

5.26

136

Injuries to the shoulder and upper arm

259

1713

1.22

2.47

1.1

1.10

1.08

u/l

0.21

117

792

Other disorders of conjunctiva

225

1.69

2.46

1.1

1.22

1.13

u/l

0.18

116

Allergic conjunctivitis

213

1675

1.24

2.45

1.1

1.00

1.06

u/l

1.66

740

Other and unspecified drugs and medicaments

188

1.76

2.44

1.1

1.07

1.13

u/l

0.21

Other noninfective gastroenteritis and colitis

545

1.43

2.44

1.1

1.19

1.06

u/l

0.62

242

Heartburn

203

1.73

2.44

1.1

1.02

1.10

u/l

0.59

Other viral diseases, not elsewhere classified

454

1.48

2.43

1.1

1.04

1.06

u/l

0.15

207

Peripheral artery disease

525

0.62

2.43

1.0

1.1

0.95

1.07

u/l

3.07

266

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

472

1.47

2.43

1.0

1.1

0.97

1.05

u/l

0.98

189

Other disorders of patella

423

1.49

2.43

1.0

1.1

1.04

1.07

u/l

0.26

179

Supplementary factors related to causes of morbidity and mortality classified elsewhere

102

748

1.37

2.42

1.1

1.03

1.05

u/l

0.11

332

Perforation of tympanic membrane

211

1.71

2.42

1.1

0.95

1.11

u/l

2.79

103

Weight loss

189

1.75

2.40

1.2

1.1

1.16

1.13

u/l

0.10

101

Obesity and other hyperalimentation

228

1791

1.23

2.39

1.1

1.18

1.05

u/l

0.39

101

794

Type of accident

682

1.38

2.39

1.1

1.04

u/l

0.01

301

Spasmodic torticollis

2.36

2.39

1.0

1.1

1.18

1.09

u/l

—

Other diseases of arteries and capillaries

160

1.82

2.39

1.1

1.14

u/l

0.02

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

674

1.38

2.38

1.0

1.1

1.12

1.10

u/l

0.05

307

Other and unspecified effects of external causes

101

742

1.36

2.38

1.1

1.04

1.05

u/l

0.10

332

Early lumbar disc prolapse operation

321

1.56

2.37

1.1

1.05

1.03

u/l

0.18

143

Cholecystitis

220

1.69

2.37

1.1

1.18

1.09

u/l

0.23

111

Protozoal diseases

2.63

2.36

1.4

1.1

1.30

1.09

u/l

—

Normal-pressure hydrocephalus

2.51

2.36

1.2

1.1

1.17

1.28

u/l

—

Other disorders of white blood cells

111

1.99

2.35

1.2

1.1

0.97

1.14

u/l

1.70

Trigger finger

228

1.67

2.35

1.1

1.05

1.15

u/l

0.94

114

Suicide or other Intentional self-harm

668

1.38

2.34

1.1

1.09

1.05

u/l

0.45

300

Obesity

227

1790

1.22

2.34

1.1

1.18

1.05

u/l

0.40

101

793

Methotrexate

244

1.64

2.33

1.1

1.0

1.05

1.10

u/l

0.45

112

Oter anti-inflammatory and antirheumatic agents, non-steroids

178

1.58

2.32

1.1

1.14

u/l

0.00

Caries of enamel

320

1944

1.19

2.32

1.1

1.08

1.07

u/l

0.12

134

877

Lesion of radial nerve

2.32

1.0

1.1

1.41

1.11

u/l

—

Other CVD

268

1.61

2.30

1.2

1.1

1.23

1.11

u/l

0.29

138

Diseases of tongue

105

2.01

2.30

1.1

1.0

1.19

1.14

u/l

—

Unspecific neurodegenerative disorder

345

1.45

2.30

1.1

1.05

1.09

u/l

0.45

169

Chronic conjunctivitis

2.39

2.29

1.1

0.99

1.09

u/l

—

Fracture at wrist and hand level

115

866

1.33

2.29

1.0

1.1

1.07

1.10

u/l

0.11

395

Other inflammation of eyelid

261

1.61

2.28

1.2

1.0

1.07

1.11

u/l

0.17

124

Other erythematous conditions

2.24

2.28

1.1

1.02

1.10

u/l

—

Familial hypercholesterolemia

185

1.73

2.27

1.1

1.10

1.12

u/l

0.05

Unspecified dementia

2.13

2.27

1.0

1.41

1.23

u/l

—

Degeneration of macula and posterior pole

532

1.38

2.26

1.1

1.07

1.08

u/l

0.17

267

Adverse effects, not elsewhere classified

521

1.42

2.26

1.1

1.04

1.06

u/l

0.16

227

Lateral epicondylitis

231

1.65

2.25

1.0

1.1

1.10

1.12

u/l

0.07

115

Use of levodopa decarboxylase inhibitor

178

1.75

2.25

1.1

1.03

1.18

u/l

1.12

Other diseases of stomach and duodenum

106

1.99

2.25

1.0

1.05

1.19

u/l

—

Lung diseases due to external agents

193

1.71

2.25

1.1

1.13

1.14

u/l

0.06

Mouth breathing

119

904

1.32

2.25

1.0

1.1

0.94

1.11

u/l

3.94

443

Malignant neoplasm of digestive organs

481

0.62

2.24

1.1

1.97

1.04

u/l

0.59

228

Malignant melanoma of skin, including Hilmo

216

1.67

2.24

1.1

1.04

1.05

u/l

0.06

Adenomyosis (Endometriosis of uterus)

294

1.57

2.24

1.1

1.25

1.05

u/l

0.44

127

Other keratitis

271

1.59

2.22

1.0

1.1

1.11

1.10

u/l

0.04

124

Other and unspecified iron deficiency

640

1.38

2.22

1.0

1.1

1.23

1.05

u/l

0.65

289

Neovascular glaucoma

2.34

2.22

1.2

1.1

1.07

1.15

u/l

—

Excessive, frequent and irregular menstruation

154

658

1.28

2.22

1.1

1.04

1.03

u/l

0.04

278

Aplastic and other anaemias

105

732

1.34

2.21

1.1

1.19

1.05

u/l

0.91

351

Intermittent heterotropia

128

1.88

2.20

1.0

1.1

1.15

1.04

u/l

0.34

Obesity due to excess calories

170

1358

1.25

2.20

1.1

1.25

1.04

u/l

0.49

583

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

241

1.62

2.18

1.1

1.06

1.05

u/l

0.07

108

Special screening examination for other diseases and disorders

165

1.76

2.18

1.1

1.0

1.01

1.11

u/l

0.54

Injuries to the abdomen, lower back, lumbar spine and pelvis

114

857

1.32

2.17

1.1

1.02

1.04

u/l

0.17

380

Diseases of middle ear and mastoid

217

1454

1.22

2.17

1.1

1.04

1.03

u/l

0.07

621

Schizophrenia

413

0.56

2.15

1.0

1.1

1.18

1.06

u/l

—

195

Endometriosis ASRM stages 1,2

510

1.42

2.15

1.0

1.1

0.93

1.05

u/l

1.96

210

Use of donepezil

180

1.70

2.14

1.1

1.03

1.15

u/l

1.12

Cardiodefibrillation

547

0.62

2.11

1.0

1.1

0.92

1.08

u/l

3.31

268

Inflammatory diseases of prostate (prostatitis)

182

1.71

2.11

1.0

1.1

0.94

1.02

u/l

0.81

Fitting and adjustment of other devices

476

1.40

2.10

1.1

1.01

1.07

u/l

0.81

217

Dislocation, sprain and strain of joints and ligaments of knee

218

1656

1.21

2.09

1.1

1.04

1.08

u/l

0.56

733

Nutritional anaemias

130

975

1.29

2.09

1.0

1.1

1.50

1.05

u/l

0.83

444

Other superficial mycoses

2.58

2.08

1.3

1.1

1.03

1.07

u/l

—

Primary angle-closure glaucoma

2.27

2.08

1.0

0.93

1.24

u/l

—

Bleeding

231

1359

1.21

2.07

1.1

1.05

1.09

u/l

0.33

111

633

Carcinoma in situ of skin of other and unspecified parts of face

2.03

2.05

1.1

1.29

1.26

u/l

—

Varicella [chickenpox]

1.99

2.05

1.1

1.26

1.09

u/l

—

Respiratory disorders in diseases classified elsewhere

3.11

2.02

1.1

1.0

1.11

1.16

u/l

—

Elevated blood glucose level

162

1.73

2.01

1.1

0.93

1.14

u/l

2.71

Retinal detachment with retinal break

200

1.65

2.01

1.1

1.06

1.14

u/l

0.38

107

Other bacterial intestinal infections

335

1.50

2.00

1.2

1.1

1.09

1.08

u/l

0.04

160

Mixed and other personality disorders

216

1.63

2.00

1.1

1.04

u/l

0.02

102

Achilles tendinitis

170

1.71

1.99

1.0

1.1

0.94

1.09

u/l

1.70

KRA_PSY_EATING, excluding more controls

215

1.62

1.99

1.0

1.1

1.08

1.05

u/l

0.09

Torsion of ovary, ovarian pedicle and fallopian tube

2.30

1.98

1.1

1.00

1.04

u/l

—

Hyperkinetic disorders

377

1.46

1.97

1.0

1.1

0.95

0.98

u/l

0.35

157

Calculus of kidney and ureter

579

1.37

1.95

1.1

1.08

1.06

u/l

0.14

269

Glaucoma secondary to other eye disorders

2.20

1.94

1.2

1.0

1.07

1.25

u/l

—

Noninfectious colitis NAS

305

1.51

1.94

1.1

1.08

1.09

u/l

0.07

145

Other/unspecified enthesopathies, not elsewhere classified

127

1.82

1.93

1.0

1.08

1.16

u/l

0.32

Disorders of gallbladder, biliary tract and pancreas

313

1687

1.17

1.93

1.1

1.13

1.07

u/l

0.65

131

766

Bacterial intestinal infections, IBD co-morbidities

330

1.49

1.92

1.2

1.1

1.06

1.10

u/l

0.27

160

Osteonecrosis

113

1.87

1.91

1.0

1.1

1.15

1.17

u/l

—

Gastric ulcer

258

1.55

1.91

1.1

1.00

1.09

u/l

0.84

128

Anankastic personality disorder

106

1.90

1.91

1.0

1.1

1.09

1.03

u/l

—

Disorder of lipoprotein metabolism, unspecified

173

1.68

1.89

1.1

1.19

1.11

u/l

0.24

Diseases of male genital organs

143

570

1.27

1.88

1.1

1.06

1.11

u/l

0.36

276

Other disorders of penis

143

1.75

1.88

1.1

0.99

1.03

u/l

0.25

Anogenital herpesviral [herpes simplex] infection

332

1.48

1.88

1.1

1.00

1.02

u/l

0.16

133

Hypotension

220

1.59

1.87

1.2

1.1

1.30

1.15

u/l

0.28

111

Undefined dementia

1.95

1.86

1.0

1.41

1.25

u/l

—

Radial styloid tenosynovitis [de Quervain]

107

1.88

1.86

1.0

1.1

1.00

1.14

u/l

1.13

Heart failure, not strict

197

1103

1.21

1.85

1.1

1.15

1.10

u/l

0.48

530

Asthma mixed form (mode)

2.03

1.85

1.1

1.0

1.07

1.17

u/l

—

Other disorders of glucose regulation and pancreatic internal secretion

182

1.65

1.84

1.0

1.1

1.07

1.14

u/l

0.29

Coronary artery bypass grafting

285

0.57

1.84

1.0

1.1

1.47

1.10

u/l

—

156

Fall on same level involving ice and snow

170

1390

1.22

1.84

1.1

1.19

1.07

u/l

0.89

629

Superficial injury of lower leg

603

1.35

1.84

1.1

0.98

1.05

u/l

1.41

263

Noninfective enteritis and colitis

147

1182

1.24

1.83

1.1

1.08

1.05

u/l

0.26

515

Hyperplasia of prostate

328

1.37

1.83

1.1

1.10

1.15

u/l

0.22

171

Thyroiditis

152

1.72

1.83

1.2

1.1

0.94

1.09

u/l

1.42

Impingement syndrome of shoulder

392

1.43

1.82

1.0

1.1

0.97

1.19

u/l

1.84

202

Other and unspecified urticaria

502

1.38

1.81

1.1

1.10

1.06

u/l

0.20

215

Other disorders of bone density and structure

2.28

1.81

1.0

1.1

1.04

1.05

u/l

—

Sacrococcygeal disorders, not elsewhere classified

2.28

1.81

1.1

1.09

1.05

u/l

—

Hyperhidrosis

2.28

1.81

1.0

0.86

1.11

u/l

—

Amblyopia ex anopsia

2.06

1.80

1.0

1.00

1.02

u/l

—

Diaphragmatic hernia

684

1.32

1.78

1.1

1.05

1.07

u/l

0.19

336

Diabetes mellitus

359

1825

1.15

1.77

1.1

1.07

1.08

u/l

0.12

170

811

Explicit bacterial Sepsis

161

1.68

1.77

1.1

1.53

1.14

u/l

0.83

Tongue abnormality

109

1.84

1.77

1.1

1.19

1.16

u/l

—

Pruritus

216

1.58

1.76

1.1

1.05

1.11

u/l

0.22

Degenerative macular diseases

154

1.69

1.75

1.1

1.08

1.16

u/l

0.48

Other and unspecified vascular occlusions

124

1.78

1.75

1.2

1.1

0.99

1.21

u/l

—

Sulfasalazine

617

1.33

1.75

1.0

1.25

1.05

u/l

0.64

273

Congenital malformations and deformations of the musculoskeletal system

279

1.50

1.74

1.1

0.99

1.03

u/l

0.27

123

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

489

1.37

1.74

1.1

1.08

1.04

u/l

0.24

210

Other disorders of adrenal gland

1.88

1.71

1.5

1.1

1.15

1.06

u/l

0.31

Iron deficiency anaemia

109

843

1.28

1.70

1.0

1.1

1.52

1.05

u/l

0.73

379

Other benign neoplasm of uterus: Other parts/unspecified

0.00

1.70

0.0

1.0

—

1.34

—

Other embolism and thrombosis

226

1.55

1.70

1.0

1.1

0.98

1.12

u/l

1.74

113

Atherosclerosis, excluding cerebral and coronary sclerosis

468

0.68

1.69

1.1

0.95

1.08

u/l

3.27

233

Asthma mixed form (mode), excluding more controls

1.96

1.69

1.1

1.0

1.07

1.17

u/l

—

Major coronary heart disease event

225

1144

1.19

1.69

1.0

1.1

1.04

1.11

u/l

0.97

114

569

Type 2 diabetes

335

1702

1.15

1.68

1.1

1.07

1.08

u/l

0.08

158

765

Atopic dermatitis

218

1508

1.19

1.67

1.1

0.97

1.06

u/l

2.53

656

Polycystic ovarian syndrome, consortium definition

261

1320

1.17

1.67

1.1

1.03

1.05

u/l

0.29

117

554

Noninflammatory disorders of female genital tract

163

667

1.23

1.67

1.1

1.13

1.03

u/l

0.84

281

Secondary polycythaemia

2.52

1.67

1.0

1.1

0.92

1.09

u/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

562

1.34

1.66

1.0

1.1

0.99

1.06

u/l

0.75

263

Colorectal adenocarcinoma

253

0.51

1.66

1.0

1.1

4.12

1.05

u/l

—

112

Injury of nerves at wrist and hand level

1.90

1.65

1.1

1.09

u/l

—

Type 1 diabetes, strict definition

252

0.51

1.65

1.2

1.1

0.85

1.01

u/l

—

103

Renal tubulo-interstitial diseases

272

1742

1.16

1.65

1.1

1.10

1.07

u/l

0.30

108

791

Hypertrophic disorders of skin

142

1.70

1.64

1.1

1.03

1.07

u/l

0.20

Urolithiasis

615

1.32

1.64

1.1

1.08

1.06

u/l

0.14

291

Pneumonitis due to solids and liquids

112

1.79

1.64

1.1

1.0

1.10

1.21

u/l

0.36

Ménière disease

173

1.62

1.63

1.0

1.01

1.10

u/l

0.83

Myocardial infarction, strict

609

0.74

1.63

1.1

1.25

1.12

u/l

0.59

329

Candidiasis

310

1.45

1.63

1.1

1.18

1.09

u/l

0.47

143

Otitis externa

521

1.35

1.63

1.0

1.1

0.97

1.07

u/l

1.62

231

Diabetes, varying definitions

354

1817

1.14

1.62

1.1

1.07

1.08

u/l

0.09

166

809

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

205

1.57

1.62

1.0

1.1

1.02

1.06

u/l

0.22

Fracture of lower leg, including ankle

160

1308

1.21

1.61

1.1

1.09

u/l

0.02

591

Other gastritis (incl. Duodenitis)

386

1.40

1.60

1.2

1.1

1.27

1.08

u/l

1.00

183

Use of rivastigmine

135

1.70

1.60

1.2

1.1

1.05

1.21

u/l

1.30

Benign neoplasm: Choroid

113

1.78

1.60

1.2

1.1

1.03

1.18

u/l

—

Haemorrhoids and perianal venous thrombosis

599

1.32

1.60

1.1

1.03

1.08

u/l

0.45

278

Gluteal tendinitis

2.07

1.60

1.2

1.1

1.61

1.13

u/l

—

Myocardial infarction

647

0.75

1.59

1.1

1.20

1.12

u/l

0.41

342

Nonspecific lymphadenitis

136

1.70

1.58

1.2

1.1

1.03

1.04

u/l

0.11

Other and unspecified tonsillitis

135

921

1.23

1.58

1.1

0.98

1.09

u/l

1.42

403

Perineal laceration during delivery

545

0.70

1.58

1.0

1.1

1.19

0.98

u/l

1.11

200

Haemorrhage from respiratory passages

534

1.32

1.57

1.1

1.01

1.12

u/l

0.86

251

Later onset COPD

260

0.58

1.57

1.1

1.07

1.10

u/l

—

132

Mental disorders, not otherwise specified

239

1.51

1.57

1.1

1.13

1.04

u/l

0.45

110

Other specified and unspecified personality disorders

239

1.51

1.57

1.1

1.02

1.06

u/l

0.26

110

Benign neoplasm: Ascending colon

215

1.54

1.56

1.2

1.1

1.07

1.13

u/l

0.18

108

Oligomenorrhoea

1.86

1.56

1.2

1.1

1.33

1.01

u/l

—

Ovarian dysfunction

256

1.49

1.55

1.0

1.1

1.07

1.00

u/l

0.32

102

Malignant melanoma, including Hilmo

256

1.49

1.54

1.1

1.03

1.04

u/l

0.10

115

Excessive attrition of teeth

195

1649

1.18

1.54

1.1

1.09

1.07

u/l

0.17

736

Parkinson's disease, including avohilmo

216

1.53

1.1

0.99

1.15

u/l

1.94

104

Viral warts

553

1.32

1.53

1.0

1.1

1.00

1.06

u/l

0.64

247

Medicines for HER+ breast cancer

711

0.73

1.53

1.0

1.1

1.00

1.10

u/l

1.22

331

Cardiomyopathy, other and unspecified

130

1.70

1.52

1.2

1.1

1.04

1.17

u/l

0.78

Chondropathies

365

1.40

1.52

1.0

1.1

1.01

1.08

u/l

0.91

172

Disorders of parathyroid gland

311

1.43

1.51

1.1

1.0

1.27

1.09

u/l

0.47

152

Type 1 diabetes, strict definition, subgroup 1

244

0.53

1.51

1.2

1.1

0.85

1.01

u/l

—

Parkinson's disease, strict definition

185

1.57

1.51

1.1

0.97

1.18

u/l

2.65

Disorders of breast

164

1241

1.20

1.50

1.1

1.06

u/l

0.02

529

Other eating disorders

154

1.63

1.49

1.0

0.94

1.02

u/l

—

Burns and corrosions confined to eye and internal organs

2.08

1.49

1.0

1.1

0.99

1.08

u/l

—

Bicipital tendinitis

1.95

1.49

1.0

0.98

1.22

u/l

—

Other sexually transmitted chlamydial diseases

218

1.52

1.48

1.0

1.1

1.00

u/l

—

Percutaneous Coronary Intervention

210

1093

1.18

1.48

1.1

1.05

1.11

u/l

0.87

108

549

Ankylosing spondylitis, ICD10

210

1.53

1.48

1.1

1.46

1.07

u/l

0.59

105

Other disorders of cornea

186

1.56

1.48

1.0

1.1

1.08

1.12

u/l

0.18

Injuries to the hip and thigh

116

847

1.24

1.48

1.1

1.07

1.05

u/l

0.18

396

Paralytic ileus and intestinal obstruction

435

1.36

1.47

1.1

1.00

1.09

u/l

0.97

213

False labour

137

698

1.23

1.47

1.1

0.98

1.04

u/l

0.79

268

Recurrent dislocation of patella

155

1.62

1.46

1.1

1.00

1.01

u/l

—

Overexertion and strenuous or repetitive movements

235

1.49

1.46

1.0

1.1

1.07

1.12

u/l

0.22

115

Other blood glucose lowering drugs, excl. Insulins

235

1.49

1.46

1.1

1.17

1.11

u/l

0.44

116

Coronary revascularization (ANGIO or CABG)

210

1094

1.18

1.45

1.1

1.04

1.11

u/l

0.89

107

549

Budesonide

293

1.44

1.45

1.1

1.0

1.04

1.08

u/l

0.21

128

Cholelithiasis, broad definition with cholecystitis

264

1541

1.15

1.45

1.1

1.13

1.08

u/l

0.50

113

697

Superficial injury of neck

2.13

1.45

1.1

0.98

1.07

u/l

—

Misadventures to patients during surgical and medical care

285

1.44

1.1

1.11

u/l

0.01

135

Open wound of wrist and hand

143

1157

1.21

1.44

1.1

1.00

1.09

u/l

1.37

536

Urethral stricture

1.92

1.43

1.0

1.09

1.16

u/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.98

1.43

1.3

1.1

1.11

1.04

u/l

—

Erysipelas

191

1236

1.18

1.43

1.1

1.16

1.07

u/l

0.80

575

Other condition

319

1.41

1.43

1.1

1.09

1.07

u/l

0.09

151

Schizophrenia or delusion, excluding more controls

658

1.28

1.42

1.0

1.1

0.99

1.06

u/l

0.77

299

Superficial injury of hip and thigh

261

1.46

1.42

1.1

0.96

1.11

u/l

2.98

125

Other bursopathies

188

1.55

1.42

1.0

1.1

0.97

1.14

u/l

1.92

Use of other anti-dementia drugs

202

1.48

1.41

1.0

1.1

1.12

1.14

u/l

0.13

108

Use of memantine

202

1.48

1.41

1.0

1.1

1.12

1.14

u/l

0.13

108

Other diseases of oesophagus

149

1.61

1.40

1.1

1.02

1.16

u/l

1.14

Congenital malformations of ovaries, fallopian tubes and broad ligaments

157

1.60

1.40

1.0

1.1

1.25

1.06

u/l

0.24

Other epidermal thickening

1.86

1.40

1.1

1.0

0.94

1.09

u/l

—

Superficial injury of head

492

1.32

1.39

1.1

1.04

1.05

u/l

0.09

220

Streptococcal septicaemia

134

1.65

1.39

1.1

1.62

1.10

u/l

—

Alzheimer’s disease, strict definition

195

1.48

1.38

1.1

1.02

1.16

u/l

1.92

103

Malignant neoplasm of breast, HER-positive

513

0.73

1.38

1.0

1.1

0.99

1.06

u/l

0.63

232

Rheumatoid arthritis, including avohilmo

793

1.25

1.38

1.1

1.22

1.07

u/l

0.74

365

Other disorders of the genitourinary system

214

1.50

1.37

1.0

1.1

1.04

1.09

u/l

0.39

104

Vasomotor rhinitis (mode)

158

1.59

1.37

1.2

1.1

0.92

1.11

u/l

3.12

Parkinson's disease

206

1.51

1.37

1.1

0.99

1.16

u/l

1.95

Recurrent dislocation and subluxation of joint

174

1.56

1.37

1.0

1.1

1.05

u/l

0.01

Enterocolitis due to Clostridium difficile

174

1.55

1.36

1.2

1.1

1.10

1.15

u/l

0.15

Emergency coronary revascularization (for ACS)

219

1144

1.16

1.36

1.1

1.04

1.11

u/l

0.88

111

572

Ankylosing spondylitis, strict definition

112

1.70

1.35

1.0

1.1

1.70

1.06

u/l

—

HSIL lesion of the vagina

0.00

1.35

0.0

1.1

—

1.13

—

Iron deficiency

1.88

1.34

1.3

1.1

0.96

1.08

u/l

—

Amputation of foot

0.00

1.34

0.0

1.0

—

1.09

—

Seronegative rheumatoid arthritis

199

1.51

1.34

1.0

1.1

1.21

1.06

u/l

0.35

Benign neoplasm: Rectum, anus and anal canal

315

1.40

1.34

1.2

1.1

1.03

1.11

u/l

0.78

152

Other diseases of hard tissues of teeth

168

730

1.19

1.34

1.1

1.04

1.08

u/l

0.63

345

Other appendicitis

175

1.55

1.34

1.0

1.1

0.87

1.13

u/l

—

Other infectious diseases

167

1.56

1.34

1.2

1.1

1.13

1.15

u/l

0.08

Antenatal screening

465

0.76

1.33

1.0

0.99

1.06

u/l

0.77

180

Burn and corrosion confined to eye and adnexa

2.05

1.33

1.0

1.1

1.00

1.08

u/l

—

All-cause Heart Failure

701

0.78

1.32

1.1

1.19

1.09

u/l

0.41

357

Fentanyl

128

1.64

1.32

1.0

1.1

1.15

1.16

u/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

298

1682

1.13

1.32

1.0

1.1

1.07

1.08

u/l

0.05

131

776

Purpura and other haemorrhagic conditions

266

1.43

1.31

1.1

1.07

1.11

u/l

0.31

132

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

1.31

0.0

1.0

—

1.10

—

Abnormal findings on antenatal screening of mother

300

1.40

1.31

1.0

1.1

1.00

1.02

u/l

0.17

104

Other sexually transmitted chlamydial diseases

334

1.38

1.30

1.0

1.1

0.95

0.98

u/l

0.39

140

Assault by bodily force

217

1.48

1.30

1.1

1.08

1.05

u/l

0.29

105

Fall on and from stairs and steps

577

1.28

1.30

1.0

1.1

1.10

1.06

u/l

0.14

265

Hypertrophic scar

129

1.63

1.30

1.1

0.98

1.07

u/l

—

Other diseases of liver

377

1.36

1.29

1.1

1.16

1.08

u/l

0.28

180

Other maternal disorders predominantly related to pregnancy

211

1140

1.16

1.29

1.1

1.02

1.07

u/l

0.84

468

Reactive arthropathies, FINNGEN

137

1.61

1.29

1.0

1.1

0.91

1.06

u/l

—

Type1 diabetes, definitions combined, early onset

205

0.53

1.29

1.2

1.1

0.84

1.00

u/l

—

Unspecified privation

226

1.46

1.28

1.1

1.02

1.12

u/l

0.50

115

Alzheimer disease

231

1.39

1.28

1.1

1.03

1.14

u/l

1.18

117

Deep endometriosis

243

1.44

1.27

1.0

1.1

0.97

1.10

u/l

0.95

109

Heart failure, strict

712

0.79

1.27

1.1

1.19

1.10

u/l

0.42

364

Car occupant injured in other and unspecified transport accidents

509

1.30

1.27

1.0

1.1

0.98

1.05

u/l

1.15

232

Other follicular disorders

194

1.50

1.26

1.1

0.91

1.07

u/l

2.30

conjunctival haemorrhage

130

1.62

1.26

1.1

1.30

1.17

u/l

—

Emotional disorders starting during childhood or adolescence

129

1.62

1.26

1.1

0.92

1.00

u/l

—

Injury of muscle and tendon at shoulder and upper arm level

660

1.26

1.25

1.1

1.09

1.12

u/l

0.18

329

Abnormal serum enzyme levels

488

1.30

1.25

1.1

1.12

1.14

u/l

0.09

250

Maternal care for known or suspected malpresentation of fetus

526

0.76

1.25

1.2

1.1

1.01

u/l

0.01

208

Oesophagitis

1.74

1.25

1.1

0.98

1.19

u/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

136

1.60

1.25

1.1

1.0

0.92

0.98

u/l

—

Infections of genitourinary tract in pregnancy

278

1.41

1.24

1.1

0.94

1.06

u/l

2.52

104

Impotence

1.86

1.24

1.2

1.1

1.24

1.10

u/l

—

Congenital malformations of the circulatory system

319

1.37

1.23

1.0

1.1

1.01

1.08

u/l

0.48

158

Alzheimer disease, including avohilmo

278

1.34

1.23

1.1

1.06

1.11

u/l

0.39

139

Salpingitis and oophoritis

398

1.33

1.23

1.0

1.1

1.08

1.09

u/l

0.05

189

Chronic kidney disease

424

1.32

1.23

1.1

1.16

1.07

u/l

0.54

216

Benign neoplasm of major salivary glands

179

1.51

1.23

1.1

1.15

1.13

u/l

0.03

Agranulocytosis

220

1.46

1.23

1.1

1.25

1.10

u/l

0.79

111

Hypoglycaemia, other or unspecified

147

1.57

1.23

1.0

1.1

1.09

1.07

u/l

0.06

Malignant neoplasm, wide definition for exclusion

288

1493

1.13

1.22

1.1

1.25

1.04

u/l

1.20

149

643

L02BA Anti-estrogens

326

0.64

1.22

1.1

1.00

1.10

u/l

0.70

153

Gingivitis and periodontal diseases

331

1521

1.12

1.22

1.1

1.07

u/l

0.04

142

688

Personal history of certain other diseases

2.05

1.22

1.0

1.1

1.06

1.08

u/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

522

0.75

1.22

1.0

1.1

0.99

1.06

u/l

0.63

236

Prolonged pregnancy

511

0.73

1.22

1.0

1.1

0.90

1.01

u/l

—

199

Cholelithiasis

250

1513

1.14

1.21

1.1

1.13

1.08

u/l

0.50

107

685

Nail disorders

188

1.49

1.21

1.0

1.1

1.01

1.08

u/l

0.49

Volume depletion

124

1.62

1.20

1.1

1.0

1.10

1.14

u/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

366

0.68

1.20

1.0

1.1

1.23

1.06

u/l

0.47

174

Superficial injury of wrist and hand

549

1.28

1.20

1.0

1.1

0.96

1.05

u/l

1.47

254

Otitis externa, unspecified

255

1.41

1.19

1.1

0.99

1.12

u/l

1.31

121

Dental operations

177

777

1.17

1.19

1.1

1.06

1.12

u/l

0.69

375

Postmenopausal osteoporosis with pathological fracture

1.75

1.19

1.2

1.1

1.09

1.20

u/l

—

Benign neoplasm of bone and articular cartilage

189

1.49

1.18

1.0

1.1

1.02

1.10

u/l

—

Atrial fibrillation and flutter with reimbursement

280

1.32

1.18

1.1

0.98

1.18

u/l

1.15

155

Atrial fibrillation and flutter

394

1.27

1.18

1.1

0.97

1.15

u/l

1.29

197

Seborrhoeic dermatitis

181

1.49

1.18

1.1

1.03

1.12

u/l

0.61

Hyperfunction of pituitary gland

125

1.61

1.17

1.2

1.1

1.09

1.01

u/l

—

Tobacco use

133

1.58

1.17

1.1

0.96

1.08

u/l

1.03

Diabetic retinopathy

368

1.27

1.17

1.1

1.12

1.04

u/l

0.26

180

Other infectious diseases

133

1.58

1.17

1.1

1.04

1.16

u/l

—

Type 1 diabetes, strict (exclude DM2)

297

0.64

1.17

1.2

1.1

0.89

1.02

u/l

—

127

Presence of other devices

357

1.34

1.17

1.1

1.11

1.09

u/l

0.09

169

Injuries to the elbow and forearm

216

1660

1.14

1.16

1.0

1.1

1.06

1.07

u/l

0.12

749

Other infestations

0.00

1.16

0.0

1.0

—

1.13

—

Other superficial mycoses

282

1.39

1.16

1.2

1.1

0.93

1.08

u/l

2.76

128

Premature rupture of membranes

585

0.78

1.16

1.2

1.1

0.95

1.01

u/l

1.16

235

Congenital malformations and deformations of the musculoskeletal system

222

1.44

1.15

1.1

1.00

1.04

u/l

0.19

Benign neoplasm: Colon, unspecified

394

1.32

1.15

1.1

1.08

1.09

u/l

0.04

196

Adjustment and management of implanted device

215

1.44

1.15

1.1

1.00

1.08

u/l

0.71

104

Artrosis, including avohilmo

277

1343

1.13

1.15

1.1

1.04

1.09

u/l

0.62

131

604

Superficial injury of abdomen, lower back and pelvis

351

1.34

1.15

1.0

1.1

0.99

1.08

u/l

0.85

164

Tuberculosis, IBD comorbidity

1.73

1.15

1.1

1.06

1.25

u/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

301

1.31

1.14

1.1

1.15

1.16

u/l

0.02

165

Rheumatoid arthritis

575

1.25

1.14

1.1

1.27

1.05

u/l

0.96

266

Benign neoplasm: Parotid gland

150

1.54

1.14

1.1

1.16

u/l

0.01

Helminthiases

1.69

1.14

1.1

1.20

1.07

u/l

—

Anogenital herpesviral [herpes simplex] infection

191

1.47

1.13

1.1

0.96

1.04

u/l

1.23

COPD, hospital admissions 1, only main diagnosis

435

0.73

1.13

1.1

0.95

1.09

u/l

2.83

209

Specific development disorders of scholastic skills

109

1.63

1.13

1.1

0.93

0.98

u/l

—

Cutaneous abscess, furuncle and carbuncle

643

1.25

1.13

1.1

1.00

1.05

u/l

0.30

287

Missing teeth due to accident, extraction or parodontitis

146

1172

1.17

1.12

1.1

1.14

1.09

u/l

0.26

564

Type 1 diabetes, definitions combined

294

0.64

1.12

1.2

1.1

0.89

1.02

u/l

—

126

Viral conjunctivitis

1.91

1.12

1.0

1.1

0.88

1.06

u/l

—

Event of undetermined intent

159

1.51

1.12

1.1

1.06

1.07

u/l

—

Dialysis, with operation codes

225

1.42

1.11

1.2

1.1

0.98

1.12

u/l

1.46

119

Viral conjunctivitis

1.67

1.10

1.1

1.0

0.96

1.05

u/l

—

Dermatitis due to ingested food

1.79

1.10

1.2

1.0

0.86

1.01

u/l

—

Endometriosis ASRM stages 3,4

601

1.25

1.10

1.1

0.94

1.05

u/l

2.42

248

Dermatophytosis

183

1591

1.15

1.09

1.1

1.00

1.08

u/l

1.38

707

Malignant melanoma

218

1.42

1.08

1.1

1.07

1.06

u/l

0.05

Melanocytic naevi

737

1.22

1.08

1.2

1.1

0.97

1.05

u/l

1.74

326

Assault

381

1.31

1.08

1.1

1.07

1.04

u/l

0.41

174

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

166

1247

1.16

1.08

1.0

1.1

1.03

1.07

u/l

0.44

522

Postprocedural disorders of digestive system, not elsewhere classified

1.87

1.07

1.0

1.04

1.08

u/l

—

DVT of lower extremities

304

1.35

1.06

1.1

1.05

1.10

u/l

0.41

143

Cellulitis

479

1.28

1.06

1.1

0.97

1.07

u/l

1.62

213

Septal defects

134

1.54

1.05

1.0

1.1

1.00

1.03

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

170

1.47

1.04

1.1

1.16

1.14

u/l

0.04

Transplanted organ and tissue status

195

1.44

1.04

1.1

1.09

1.12

u/l

0.13

102

Diseases of the digestive system

108

901

1.19

1.03

1.1

1.04

1.05

u/l

0.13

413

Sudden idiopathic hearing loss

187

1.45

1.03

1.1

1.01

1.10

u/l

0.47

101

Pregnancy hypertension

154

1191

1.16

1.03

1.0

1.1

1.00

1.05

u/l

1.03

492

Ventral hernia

463

0.73

1.02

1.1

1.06

u/l

0.00

220

Arthrosis

211

1018

1.14

1.02

1.1

1.08

1.09

u/l

0.09

463

Type 2 diabetes, definitions combined, including avohilmo

306

1603

1.11

1.02

1.1

1.09

u/l

0.02

146

718

Alcohol abuse, main dg, excluding more controls

281

1.35

1.01

1.1

0.99

1.07

u/l

0.74

128

Keratoconus

1.90

1.01

1.0

1.1

1.14

1.10

u/l

—

Other menopausal disorders

390

1.23

1.01

1.1

1.00

1.06

u/l

0.79

168

Other and unspecified rosacea

188

1.44

1.01

1.1

0.90

1.14

u/l

—

Disease of hard tissues of teeth, NOS

161

727

1.16

1.00

1.1

1.04

1.08

u/l

0.47

343

Malignant neoplasm of thyroid gland, including Hilmo

147

1.50

1.00

1.0

1.1

1.05

u/l

0.01

Sulfonylureas

377

0.74

1.00

1.0

1.1

1.09

1.08

u/l

0.04

193

Atopic dermatitis, strict definition with reimbursement

112

913

1.19

1.00

1.1

0.97

1.03

u/l

1.33

386

L02BG Aromatase inhibitors

562

0.76

1.00

1.0

1.1

1.02

1.11

u/l

0.71

270

Speech therapy

511

1.25

0.99

1.1

1.05

1.08

u/l

0.20

241

Polycystic ovarian syndrome

189

1.43

0.99

1.0

1.06

1.00

u/l

0.17

Other neurotic disorders

1.72

0.99

1.1

0.93

1.13

u/l

—

Infectious mononucleosis

274

1.35

0.99

1.1

0.90

0.99

u/l

1.67

118

Heart failure and coronary heart disease

479

0.78

0.98

1.1

1.20

1.07

u/l

0.55

253

Abnormal findings in secretions and smears from cervix uteri vagina vulva

183

1212

1.14

0.98

1.1

0.97

1.06

u/l

2.46

510

Follicular cysts of skin and subcutaneous tissue

405

1.29

0.98

1.1

1.06

1.08

u/l

0.12

187

Fracture of forearm

155

1232

1.15

0.98

1.0

1.1

1.09

1.06

u/l

0.20

553

Colitis, primary sclerosing

0.00

0.98

0.0

1.1

—

1.07

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

0.98

0.0

1.0

—

1.05

—

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.1

—

1.06

—

Female genital prolapse

414

1.22

0.97

1.0

1.1

1.00

1.06

u/l

0.67

176

Tuberculosis, wide

1.63

0.97

1.1

1.06

1.25

u/l

—

Otitis media, unspecified

269

1.34

0.96

1.0

1.1

0.98

1.03

u/l

0.69

115

Childhood asthma (age<16), excluding more controls

312

1.29

0.96

1.1

0.91

1.02

u/l

1.52

128

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

157

1.47

0.96

1.0

1.1

1.10

1.14

u/l

—

Bronchitis, not specified as acute or chronic

157

1.47

0.95

1.0

1.1

0.99

1.13

u/l

—

Reactive arthropathies

182

1.43

0.95

1.1

0.96

1.07

u/l

1.33

Nonsuppurative otitis media

592

1.21

0.95

1.1

0.98

1.04

u/l

0.96

253

Pain associated with micturition

233

1.38

0.95

1.1

1.08

1.11

u/l

0.14

115

Olecranon bursitis

1.69

0.95

1.2

1.0

1.15

1.16

u/l

—

Childhood asthma (age<16)

313

1.29

0.94

1.1

0.91

1.02

u/l

1.52

128

Other/unspecified synovitis and tenosynovitis

191

1.42

0.94

1.1

1.13

1.14

u/l

—

Hypoparathyroidism

1.78

0.94

1.4

1.0

1.20

1.24

u/l

—

Amenorrhoea

208

1.40

0.94

1.2

1.1

1.01

0.98

u/l

0.18

Allergic rhinitis

109

914

1.18

0.94

1.1

1.00

1.05

u/l

0.63

401

Bacterial, viral and other infectious agents

225

1.38

0.94

1.0

1.1

0.89

1.06

u/l

—

112

Papulosquamous disorders

105

888

1.18

0.94

1.1

0.98

1.07

u/l

1.18

410

Tubulo-interstitial nephritis, not specified as acute or chronic

125

1.52

0.94

1.1

1.41

1.12

u/l

—

Single delivery by forceps and vacuum extractor

351

0.77

0.93

1.1

0.99

1.02

u/l

0.17

131

Familial hypercholesterolemia, with ischemic heart disease

125

1.52

0.93

1.1

1.19

1.23

u/l

—

Atopic dermatitis, strict definition

109

906

1.18

0.93

1.1

0.97

1.04

u/l

1.63

383

Congenital malformations of genital organs

258

1.35

0.93

1.1

1.20

1.03

u/l

0.34

112

Diabetic retinopathy, excluding more controls

281

1.26

0.93

1.1

1.13

1.05

u/l

0.23

142

Gonarthrosis, primary, with knee surgery

813

0.83

0.93

1.1

1.03

1.13

u/l

1.32

403

Benign neoplasm: Transverse colon

175

1.43

0.92

1.1

0.94

1.15

u/l

2.99

Malignant melanoma of skin

175

1.43

0.92

1.1

1.09

1.06

u/l

0.15

Pedal cyclist injured in noncollision transport accidents

269

1.34

0.92

1.0

1.1

1.11

1.10

u/l

0.03

133

Benign neoplasm: Rectum

295

1.32

0.92

1.2

1.1

1.03

1.12

u/l

0.77

146

Malignant neoplasm of breast, HER-negative

321

0.70

0.92

1.0

1.1

1.25

1.06

u/l

0.47

151

Vitreous haemorrhage

184

1.42

0.91

1.0

1.1

0.98

1.14

u/l

—

Other diseases of blood and blood-forming organs

126

1.51

0.91

1.2

1.1

0.98

1.18

u/l

1.76

Bullous disorders

1.60

0.90

1.2

1.1

1.11

1.10

u/l

—

Colorectal cancer

307

0.70

0.90

1.1

2.40

1.05

u/l

0.49

142

Thyrotoxicosis with diffuse goitre

323

1.30

0.89

1.2

1.0

1.17

1.07

u/l

0.46

144

Thrombocytopenia, unspecified

135

1.48

0.89

1.1

1.12

1.17

u/l

—

Invasive ventilation

135

1.48

0.89

1.2

1.1

1.34

1.15

u/l

—

Non-small cell lung cancer, adenocarcinoma

1.69

0.88

1.1

0.97

1.15

u/l

—

Hernia of abdominal wall

1024

0.84

0.88

1.1

1.05

1.10

u/l

0.32

476

Other contact dermatitis

177

1.42

0.88

1.0

1.1

0.94

1.12

u/l

—

Colectomy operation

289

0.69

0.88

1.1

1.04

1.10

u/l

—

148

Other disorders of pigmentation

1.65

0.88

1.1

1.09

1.17

u/l

—

Endometriosis of ovary

437

1.25

0.88

1.1

0.90

1.04

u/l

3.79

176

Obesity, other/unspecified

113

969

1.17

0.87

1.1

1.03

1.05

u/l

0.31

405

Suppurative and unspecified otitis media

134

1032

1.15

0.86

1.1

1.07

1.03

u/l

0.21

427

Type 2 diabetes, definitions combined

298

1590

1.10

0.86

1.1

1.08

1.09

u/l

0.13

142

709

Congenital malformations of cardiac septa

140

1.46

0.85

1.0

1.1

1.00

1.07

u/l

—

L04AD Calcineurin inhibitors

247

1.34

0.85

1.0

1.1

1.12

1.07

u/l

0.24

124

Inflammatory disorders of breast

187

1.39

0.85

1.0

1.16

1.05

u/l

—

Retained placenta and membranes, without haemorrhage

321

0.72

0.84

1.0

1.1

1.01

1.06

u/l

—

138

Generalized epilepsy

1.57

0.84

1.0

1.1

0.92

1.06

u/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

160

1289

1.13

0.84

1.1

1.15

1.08

u/l

0.48

599

Vulvovaginal ulceration/inflammation in other diseases

162

1.42

0.84

1.1

1.28

1.04

u/l

—

Sequelae of injuries of upper limb

213

1.36

0.84

1.0

1.1

1.08

1.11

u/l

0.16

112

Unspecified mental disorder

130

1131

1.15

0.84

1.0

1.1

1.06

u/l

0.01

504

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

135

1.46

0.82

1.1

1.04

1.00

u/l

0.16

Peripheral arterial reconstruction

190

0.63

0.82

1.0

1.1

1.06

1.17

u/l

—

Peritonsillar abscess

552

1.22

0.82

1.1

1.04

1.05

u/l

0.07

239

Crushed, pushed or stepped on by crowd or human stampede

197

1.37

0.82

1.1

0.95

1.04

u/l

—

Other abnormal findings of blood chemistry

1.55

0.81

1.1

0.97

1.08

u/l

—

Other maltreatment syndromes

1.58

0.81

1.1

1.0

1.07

1.03

u/l

—

Gestational [pregnancy-induced] hypertension

845

1.17

0.81

1.0

1.1

0.99

1.03

u/l

0.58

348

Leisure time condition

409

1.25

0.80

1.1

1.00

1.08

u/l

0.98

185

Pilonidal cyst

250

1.32

0.80

1.2

1.1

1.02

1.06

u/l

0.30

112

Other and unspecified injuries of lower leg

181

1.38

0.79

1.0

1.07

1.11

u/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.79

0.0

1.0

—

1.16

—

Gestational diabetes (for exclusion)

157

965

1.13

0.79

1.1

0.99

1.02

u/l

0.34

362

Malignant neoplasm of other and ill-defined sites, including Hilmo

0.00

0.79

0.0

1.1

—

1.10

—

Other and unspecified iridocyclitis

106

1.51

0.79

1.3

1.1

1.13

1.06

u/l

—

Dementia in Alzheimer disease

124

1.43

0.78

1.1

0.99

1.18

u/l

—

Respiratory tuberculosis, confirmed

0.00

0.78

0.0

1.0

—

1.11

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

0.78

0.0

1.0

—

1.11

—

Allergic urticaria

199

1.36

0.78

1.1

1.50

1.12

u/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

165

1.40

0.77

1.1

1.01

1.06

u/l

—

ILD, hospital admission 2, with pulmonary infections

123

1.47

0.77

1.0

1.1

1.00

1.12

u/l

—

Intestinal stricture

538

1.21

0.77

1.1

1.04

1.07

u/l

0.13

252

Dermatitis due to substances taken internally

115

1.48

0.76

1.2

1.1

1.01

1.04

u/l

—

Lichen simplex chronicus and prurigo

115

1.48

0.76

1.1

0.90

1.13

u/l

—

Type 2 diabetes, strict (exclude DM1)

298

1602

1.09

0.76

1.1

1.08

1.09

u/l

0.13

143

717

Acute suppurative otitis media

100

803

1.16

0.76

1.1

1.10

1.04

u/l

0.27

330

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

280

0.71

0.76

1.1

0.96

1.05

u/l

0.90

127

Diseases of peritoneum

174

1.38

0.76

1.0

1.1

1.03

1.12

u/l

0.75

Portal vein thrombosis

0.00

0.76

0.0

1.0

—

1.06

—

Other (not insulin) diabetes medications

302

1642

1.09

0.76

1.1

1.06

1.09

u/l

0.30

144

737

Striking against or struck by other objects

103

889

1.16

0.76

1.1

1.02

1.08

u/l

0.68

396

Contact with sharp glass

1.52

0.75

1.2

1.1

0.94

1.07

u/l

—

Clear cell adenocarcinoma of kidney

1.65

0.75

1.4

1.1

1.00

1.15

u/l

—

Diverticular disease of intestine

170

967

1.12

0.75

1.1

1.02

1.12

u/l

1.72

470

Other and unspecified local infections of skin and subcutaneous tissue

197

0.66

0.75

1.2

1.1

0.98

1.12

u/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS